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ABSTRACT OF DISSERTATION 
 
 
ROLE OF SKELETAL PARACRINE SIGNALS IN THE PROLIFERATION AND CHONDROGENIC 
DIFFERENTIATION OF INTERZONE CELLS 
 
Articular cartilage in mammals has a limited intrinsic capacity to repair structural injuries 
and defects, a fact that contributes to the chronic and progressive nature of 
osteoarthritis.  Current treatment modalities do not enable articular cartilage to achieve 
a complete and permanent restoration of normal structure and function with large or 
partial thickness lesions.  In contrast to mammals, Mexican axolotl salamanders 
(Ambystoma mexicanum) have demonstrated the remarkable ability to spontaneously 
and completely repair even large joint cartilage lesions, an intrinsic healing process that 
involves interzone cells in the intraarticular space.  Further, when interzone tissue is 
transplanted into critical sized diaphyseal defects, it forms an entirely new diarthrodial 
joint in these amphibians, demonstrating a multi-differentiation potential.  Cellular and 
molecular mechanisms of this repair process, however, remain unclear.  This thesis 
examined whether paracrine signals are an important variable in the interaction 
between interzone cells and the skeletal microenvironment.  In vivo experiments in 
axolotl salamanders compared the outcomes of interzone tissue transplants placed in 
either a skeletal or non-skeletal site within the same individual.  The hypothesis tested 
was that the interzone-mediated repair of skeletal defects is regulated by mechanisms 
that are localized to the skeletal microenvironment.  Interzone cell proliferation and 
differentiation was only observed in skeletal transplant sites, suggesting that local 
signals from the skeletal microenvironment played a vital role in the interzone-mediated 
repair process.  In a second series of experiments, paracrine regulation of the 
proliferation and chondrogenic differentiation of equine interzone cells was evaluated in 
an in vitro co-culture system.  The results of cellular proliferation studies indicated a 
mitogenic effect of skeletal paracrine signals on interzone cells.  Expression of cartilage 
 
 
biomarker genes, evaluated at both RNA and protein levels, were used to assess 
chondrogenic differentiation.  The in vitro findings suggested that paracrine signals may 
have a role in the chondrogenic differentiation of interzone cells, but were not 
compelling.  The response may have been limited by levels of paracrine factor 
accumulation achieved in the co-culture system used for these experiments.  Taken 
together, however, the data support a model that paracrine factors from skeletal tissues 
are important regulators of interzone cell proliferation and differentiation.  This 
knowledge advances the assessment of interzone cells as a potential cell-based therapy 
for the repair of articular cartilage injuries. 
KEYWORDS: Articular cartilage, Interzone, Paracrine, Equine, Axolotl salamander 
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Chapter 1 
Background and literature review 
Introduction 
Articular cartilage covers adjoining bone surfaces in healthy synovial joints.  It is 
an aneural, alymphatic, and avascular tissue composed of a single cell type – articular 
chondrocytes.  The cells synthesize and maintain a collagen- and proteoglycan-rich 
matrix that is uniquely adapted to resist compressive and shear forces, absorb and 
redistribute loads, and enable near frictionless movement of the articulating surfaces 
[1]. However, not all of the characteristics of articular cartilage are positive.  One major 
problem, also seen in other highly specialized tissues, is a severely limited ability to 
repair or regenerate after structural injury.  Whether the lesion is due to physical 
trauma or disease, articular cartilage structural defects often progress over time [1-10].  
Deep cartilage defects that extend into the subchondral bone gain access to 
mesenchymal cells and a blood supply in the bone marrow facilitating some level of 
repair.  However, the fibrocartilage repair tissue that develops in mammals with full 
thickness lesions has inferior biochemical and biomechanical characteristics compared 
to normal hyaline cartilage, compromising long-term function and structural integrity.  
Chondral defects that remain superficial have even less spontaneous healing capacity, 
because the intact calcified cartilage layer and subchondral bone acts as a physical 
barrier to a blood supply and the bone marrow stem cells [1, 8].  For this reason, a fairly 
common surgical strategy offered to patients with joint surface chondral defects is to 
extend the structural lesion and penetrate the subchondral bone plate with the goal of 
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enhancing formation of fibrocartilage repair tissue and articular resurfacing.  
Unfortunately, the fibrocartilage that forms following surgical intervention often fails 
over time for the same reasons as the fibrocartilage that develops spontaneously in full 
thickness articular lesions.  As such, these approaches have limited success long-term, 
especially with lesions of significant dimension or in patients that try to return to a high 
level of physical activity [4, 11].  In most cases, osteoarthritis and the progressive loss of 
joint function is the eventual clinical outcome. 
The limitations of existing medical and surgical options for articular cartilage 
repair have led to a search for better therapies in the field of tissue engineering.  Novel 
strategies are aimed at restoring hyaline cartilage by implanting cells co-delivered with 
growth factors packaged in appropriate biomaterial scaffolds to replicate the native 
cartilage tissue [8, 12-14].  While some progress has been made in exploring each of the 
above components, the ultimate therapeutic goal of generating a viable, functional, and 
durable repair tissue that is biomechanically and structurally identical to normal 
articular cartilage, remains elusive.  A brief overview of the complex architecture of 
articular cartilage will facilitate an understanding of the challenges associated with 
restoring the tissue’s structure and function after injury. 
Articular cartilage – composition and ultrastructure 
Articular cartilage is a highly specialized tissue with unique biomechanical 
properties that are a function of its ultrastructure composition and complex 
organization.  Chondrocytes are the resident cell types in articular cartilage.  They 
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synthesize, maintain, and remodel the extracellular matrix (ECM), but comprise less 
than 2% of the overall tissue volume.  They exist in a physiological state of hypoxia due 
to the absence of localized vascularization, and have a low turnover rate.  However, 
their viability and unique functional properties are supported by local paracrine signals 
and biomechanical forces, both of which are crucial to maintaining cartilage health [1, 
15-18].   
Major molecular components of cartilaginous tissues include water, collagen, 
and proteoglycans, but there are also many non-collagenous proteins and glycoproteins 
present in minor quantities [19].  Collagens constitute about 60% of the dry weight of 
cartilage of which type II collagen represents 90-95% and is considered a traditional 
biomarker for this tissue.  Other collagen types that are present include V, VI, IX and XII.  
However, they represent a much smaller percentage of the total collagen content of the 
matrix [1, 15, 16, 19, 20].   
Proteoglycans are the second largest group of macromolecules in the ECM and 
account for 10-15% of its wet weight.  They are heavily glycosylated proteins composed 
of about 95% polysaccharide and 5% protein.  Extensive sulfation of the proteoglycan 
side chains results in a very high electrostatic negative charge density.  This causes the 
proteoglycans to repel each other, but also draws a lot of water molecules into the 
matrix structure.  Interaction of this fluid phase with the ECM components endows 
cartilage with the ability to resist compressive forces and facilitates the delivery of 
nutrients and oxygen to this avascular tissue.  Aggrecan is the predominant 
proteoglycan of articular cartilage and represents a second widely accepted biomarker 
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[20, 21].  The composition and organization of chondrocytes and the ECM, together with 
the fluid dynamics, are central to the tissue’s viscoelastic properties and differs across 
the thickness of articular cartilage in direct relation to localized biomechanical forces.  
Broadly, cartilage can be functionally and structurally divided into four zones as 
illustrated in Figure 1.1.  The superficial zone forms the smooth gliding articulating 
surface that resists shear forces.  It is composed of elongated chondrocytes and densely 
packed, highly ordered collagen fibers arranged parallel to the articular surface.  The 
middle zone acts as a transition between the superficial and deep zone.  Here, the 
chondrocytes are more rounded, collagen fibrils are thicker, loosely packed and aligned 
obliquely to the surface.  In the deep zone, chondrocytes are arranged in a columnar 
fashion parallel to the thick collagen fibrils which are oriented perpendicular to the 
subchondral bone to aid in resisting compressive forces.  The tidemark is a histological 
feature separating the deep zone from the calcified cartilage which anchors the cartilage 
to the subchondral bone.  From the superficial to the deep zone, the water content 
decreases, while the proteoglycan content and diameter of collagen fibers increases.  
This unique and interdependent organization gives cartilage its superior loading and 
force dissipation properties, while minimizing the coefficient of friction during 
movement – all characteristics that are particularly challenging to restore if the tissue is 
injured and structurally damaged.  Injury to any part can impair the biomechanics of the 
entire complex and lead to degeneration [1, 16, 22]. 
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Pathology and Therapy 
Trauma and structural damage to articular cartilage can be the result of normal 
wear and tear from repeated cycles of loading, acute joint injuries, inflammation, toxic 
insults to chondrocytes, joint infection, and other causes.  Due to the poor intrinsic 
ability of cartilage to heal, it is common for lesions to progress over time that lead 
eventually to an irreversible loss of structure and function.  This disease process is called 
osteoarthritis or degenerative joint disease and is a major cause of joint pain and 
disability affecting an estimated 27 million adults in the United States [12, 23-26].  It is 
also a significant clinical problem in horses, accounting for up to 60% of lameness and 
joint pain [27, 28].   
Treatment strategies for articular cartilage injuries can be broadly categorized as 
palliative (medications to relieve joint inflammation and pain, surgical debridement of 
damaged cartilage, and lavage), reparative (marrow stimulation techniques), or 
restorative (osteochondral grafting, autologous chondrocyte implantation, other tissue 
engineering approaches) [1, 8-10].  Recently, restorative approaches have been a focus 
Figure 1.1: Zonal organization of articular cartilage - Histological appearance of articular 
chondrocytes in a porcine ilium (11 weeks of age) stained with Hematoxylin and Eosin (A) and 
schematic representation of the distribution of collagen fibers (B) across the thickness of articular 
cartilage.  (Adapted with permission from Shapiro et.al., 2014 and Alford and Cole, 2005). 
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of more research efforts, and in some cases achieve a considerable reduction of clinical 
symptoms [9, 29].  These include reconstruction of the injured articular cartilage with 
mature intact cartilage along with the underlying subchondral bone (osteochondral 
grafts) or the in vitro expansion of autologous chondrocytes from the patient for 
implantation at the lesion site (autologous chondrocyte implantation; ACI), a technique 
first described for humans in 1994  [30].  While successful repair of partial and full 
thickness defects in humans [9] and horses [31, 32] have been reported with ACI, the 
need to expand chondrocytes in vitro to produce sufficient cell numbers for the 
procedure and two consecutive surgical interventions has proven to be a disadvantage.  
An improvement on this technique, matrix-assisted autologous chondrocyte 
implantation (MACI), involves the use of engineered scaffolds for delivery of 
chondrocytes into the lesion to improve retention of the transplanted cells [33-37].  
However, these chondrocyte-based strategies have been hampered by challenges in 
achieving a high cell density and maintaining the differentiated state of chondrocytes in 
culture – problems that have motivated additional research in the field of tissue 
engineering for improved strategies of cartilage repair. 
Key components of tissue engineering are the cells, tissue scaffolds, and 
biologically active stimulatory molecules.  The objective is for the components to work 
together in a coordinated fashion to achieve successful repair.  Numerous natural and 
synthetic biomaterials have been explored for their ability to mimic the properties of 
native articular cartilage, including but not limited to, hyaluronan, polylactides, alginate, 
agarose, and chitosan [12, 38, 39].  While novel biomaterials [3, 40] have been 
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developed and tested for these attributes, engineering a biocompatible tissue scaffold 
that achieves the full restoration of articular cartilage has not been accomplished.  
Considering cells, the optimal source for engineering articular cartilage should be 
relatively easy to isolate and expand.  The cells must retain or be able to achieve the 
phenotype of articular chondrocytes.  The cells or engineered construct must be 
biologically compatible with the host tissue.  In addition to primary chondrocytes, 
chondroprogenitor cells have also been evaluated.  These include cells derived from 
bone marrow, fat, synovial membrane, placenta, and other tissues [41-46].  However, 
research results are highly variable and important cell biology parameters of true 
articular chondrocytes continue to be elucidated [47-49].  The commitment of 
chondroprogenitor cells to an articular cartilage phenotype is a complex and dynamic 
process that remains an area of active research [50].  On several levels, therefore, major 
challenges for widespread clinical applications remain [12].   
Cell signaling in cartilage development 
Recent studies advocate that the key to engineering a functional and long-lasting 
articular surface lies in understanding the process of articular cartilage and joint 
development with the aim of recapitulating the developmental blueprints during repair 
[3, 12, 51, 52].  Cartilage development occurs during embryogenesis and is a 
multifaceted and highly organized process [6, 53].  It begins with the formation of 
precartilaginous condensations of undifferentiated mesenchymal cells termed anlage 
[54].  This process involves cell-cell and cell-matrix interactions which lead to expression 
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of adhesion molecules such as N-cadherin, Tenascin-C, and fibronectin that facilitate cell 
aggregation and increased cell packing.  This process is orchestrated by a SRY box 9 
(SOX9) driven transforming growth factor–β (TGFβ), WNT/Beta-catenin signaling 
pathway.  Within the cartilage anlagen, the precartilaginous mesenchymal cells undergo 
differentiation into chondrocytes, a process that is governed by the SOX triad (SOX 5, 6 
and 9) [55].  This is accompanied by the expression of cartilage specific collagen types II 
and IX, and aggrecan [56].  The anlage chondrocytes then initiate the processes of 
hypertrophic differentiation and matrix mineralization starting at primary centers of 
ossification and later secondary centers of ossification.  Terminal hypertrophic 
chondrocytes die by apoptotic mechanisms in conjunction with neovascularization of 
the cartilage and the arrival of bone progenitor cells.  In mammals, the process of 
endochondral ossification continues through gestation and the early postnatal period to 
eventually fully replace cartilage anlagen with bone [57].  The processes of 
chondrogenesis are regulated by a number of signaling molecules including TGFβ, bone 
morphogenetic proteins (BMPs), insulin-like growth factors (IGFs), fibroblast growth 
factors (FGFs), and Notch, which interact with each other to coordinate cell 
proliferation, differentiation, migration, and synthesis of the extracellular matrix [12].  
Several of these factors have been evaluated as chondrogenic inducers in vitro (TGFβ1-
3, BMP2, and IGF1), while others represent interesting candidates (WNT, Notch, and 
FGF) based on their role in chondrogenesis in vivo.  TGFβ, BMP7, and Growth and 
Differentiation factor 5 (GDF5) are important in stimulating chondrogenesis and matrix 
synthesis while inhibiting cartilage degradation both in vivo and in vitro [58-65].  In 
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addition, they can potentiate the mitogenic effects of other growth factors such as IGF1, 
IGF3, and basic FGF [3, 66-68].  IGFs have been demonstrated to be important in 
proteoglycan production and homeostasis.  Used in vitro, they promote the stabilization 
of the chondrogenic phenotype.  WNT proteins have critical but diverse roles in articular 
cartilage development which is regulated either by non-canonical or β-catenin mediated 
canonical signaling pathways [69, 70].  Notch signaling plays an important role in 
postnatal articular cartilage maintenance.  Removal of Notch signals in postnatal 
cartilage leads to degeneration and signs of early osteoarthritis [71, 72].  Members of 
the FGF family have been shown to be crucial in patterning of the structures in the 
developing limb.  FGF2 stimulates cell proliferation and differentiation depending on the 
time of exposure.  FGF9 and FGF18 augment cartilage matrix synthesis and inhibit 
hypertrophic differentiation [73].  
Articular chondrocytes, which line the synovial joints, have a separate embryonic 
origin from the anlage chondrocytes [49, 50].  Joint formation begins in the limb bud 
early in development, occurring between 35 to 55 days of gestation in equine fetuses 
[74].  The appearance of interzone cells demarcates the presumptive joint sites within 
the uninterrupted mesenchymal condensations [7, 49, 75].  The interzone can be 
appreciated in mammals only in utero during early development prior to the process of 
cavitation that produces the joint space.  Figure 1.2 shows the histological appearance 
of equine interzone tissue in fetal fetlock (metacarpophalangeal) and carpal joints. 
10 
 
                       
 
 
Much progress has been made in the last few years in understanding the origin, 
fate, and possible function of interzone cells in joint morphogenesis.  Genetic cell 
lineage tracing studies in mice have demonstrated that interzone cells constitute a 
progenitor cell cohort giving rise to joint tissues including articular cartilage, synovial 
membrane, and ligaments [48-50].  Further, these authors isolated interzone cells in 
culture based on the expression of putative biomarkers such as GDF5, WNT9A, CD44, 
and GLI-3 and found that they acquired a round architecture and expressed markers of 
the chondrocyte phenotype such as type IX collagen and aggrecan.  Similar lineage 
tracing studies using matrillin-1, a molecule expressed by all chondrocytes except 
articular chondrocytes, suggested that articular cartilage development involves the 
initial interzone mesenchymal population with concurrent cell migration from flanking 
regions of the interzone [76].  In ovo cellular labeling of chick limbs have shown similar 
recruitment and migration of cells into the interzone domain from peri-joint sites [49].  
More recent lineage tracing experiments provide a better understanding of the role of 
interzone cells in joint development summarized in recent reviews [47, 50] and 
 Figure 1.2 showing the interzone (arrows) in equine fetal joints – developing 
fetlock (A) and cuboidal bones of the carpus (B) stained with Hematoxylin and 
Eosin.  Both images are at 10x (objective lens) magnification.  
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illustrated in Figure 1.3.  As per this model, GDF5 expressing interzone cells constitute 
the progenitor cell cohort for joint structures including articular cartilage.  These GDF5 
positive cells with a history of SOX9/type II collagen expression, but negative for 
matrillin-1, give rise to articular chondrocytes.  In addition to the in situ based studies 
using candidate genes summarized above, an unbiased genome-wide expression 
analysis identified genes differentially expressed in the intermediate and outer layers of 
the interzone, dissected by laser capture microdissection.  The authors reached the 
conclusion that the cells of the intermediate layer of the interzone form the articular 
tissues including cartilage [77].  A study by Schwartz et. al. suggests an influx model of 
cell specification where interzone cells are continuously recruited into the domain of 
GDF5 expression and differentially contribute to the development of joint tissues [78].  
Taken together, these studies promote the view that interzone cells are the progenitor 
cells for articular cartilage.     
                                  
 
 
 
Figure 1.3 depicting the current model for articular cartilage and joint development.  During early developmental 
stages, unknown upstream mechanisms demarcate the presumptive joint site (A) where the initial population of 
GDF5 expressing interzone cells appears (B).  Along with TGFBR2 expressing cells from the peri-joint sites, the 
interzone cells give rise to the Matrillin-negative articular chondrocytes and other joint structures (C) and (D).  
Note that the steps presented as distinct for illustration purposes may be overlapping processes in the biological 
system (Adapted with permission from Decker et. al., 2014). 
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Interzone cells in cartilage repair  
 Experiments from our laboratory have demonstrated a role of interzone cells in 
the complete and spontaneous repair of large articular cartilage defects in adult axolotl 
salamanders (Ambystoma mexicanum) [79].  The importance of interzone was further 
emphasized by the failure of joint lesion repair with subsequent joint arthrodesis 
following surgical ablation of the interzone (unpublished observation).  Furthermore, 
when transplanted into a critical sized bone defect (CSD) in the tibia diaphysis, the 
defect closed, but with the formation of a new diarthrodial joint rather than diaphyseal 
bone [80].  The repair tissue that bridges the bone gap is a patterned structure 
resembling an intact joint with interzone positioned between two cartilaginous layers 
that are morphologically similar to epiphyseal/articular and metaphyseal chondrocytes.  
Tracking the interzone cells using green fluorescent protein (GFP) immunostaining 
revealed that the cells within the accessory joint originate from the transplanted 
interzone cells as illustrated in Figure 1.4.  Interestingly, although the interzone 
transplant was placed in a random orientation in the skeletal defect, the accessory joints 
that formed in multiple biological replicates followed correct spatial patterning 
(discussed in more detail in Chapter 2).  These observations suggest that interzone cells 
play a critical role in the repair of skeletal defects, a process that is likely mediated and 
organized by intrinsic and extrinsic signaling cues. 
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Important knowledge gaps and questions 
Studies outlined above have demonstrated a central role for interzone cells in 
diarthrodial joint development, a differentiation commitment that the axolotl studies 
suggest might also facilitate cell-based therapies to repair articular cartilage lesions.  
However, many questions remain with regard to interzone cells and cartilage repair.  
Are interzone cells autonomously regulated, directing their own proliferation and 
differentiation to form articular cartilage and other synovial joint tissues?  Or, are 
interzone cells regulated by neighboring cells, mechanisms that might be niche-
dependent and sensitive to different tissue microenvironments?  What are the specific 
signaling pathways that regulate the interzone-mediated cartilage repair process and de 
novo new joint formation observed in axolotl salamanders?  It is possible that many of 
the signaling molecules that orchestrate synovial joint development during 
embryogenesis are retained in adult tissues or possibly re-expressed following tissue 
Figure 1.4 showing the repair of the critical sized defect in the tibia with formation of a cartilage-like tissue (A) 
which histologically exhibits the anatomical organization of an intact joint with an interzone between two 
cartilaginous columns (B).  Cells within the repair tissue appear to be derived from the transplanted interzone 
cells based on GFP immunostaining (C) (Adapted with permission from Cosden-Decker et. al., 2012).  A and B 
are at 4X and C is at 40x (objective lens) magnification.  
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injury.  If so, adult tissues might have the potential to regulate interzone cell 
proliferation, migration, and differentiation in a repair context.  GFP cell tracing data 
indicated that interzone tissue transplanted into the diaphyseal bone defect of axolotl 
salamanders remained localized.  Therefore, the major focus of this dissertation is on 
the proliferation and chondrogenic differentiation of interzone cells in response to 
environmental stimuli.  Unfortunately, further studies in the axolotl model to explore 
these interactions are significantly impaired by the absence of a reference genome or 
the ability to culture amphibian cells in vitro.  For these reasons, tissue culture 
experiments were conducted with fetal and adult equine cells. 
 
Dissertation overview 
The studies presented here are designed to further investigate the biology of 
interzone cells in a tissue repair context, generating knowledge relevant to emergent 
cell-based therapies for articular cartilage lesions.  Experiments reported in Chapter 2 
test the hypothesis that the repair of skeletal defects by interzone cells is regulated by 
mechanisms that are localized to the microenvironment of skeletal tissues.  Chapters 3 
and 4 describe experiments conducted with primary equine cell lines, both fetal and 
adult.  They test the hypothesis that paracrine signals derived from the skeletal 
microenvironment induce the proliferation and chondrogenic differentiation of 
interzone cells in culture.  Finally, chapter 5 will reflect on work performed so far and 
propose directions for further studies to understand the role of interzone cells in 
cartilage repair.   
15 
 
 
Chapter 2 
Effect of the skeletal microenvironment on interzone mediated repair of skeletal 
defects 
 
Introduction  
Articular cartilage is a highly specialized tissue that covers adjoining bone surfaces in 
synovial joints, redistributing the mechanical forces that occur during skeletal loading 
and facilitating low-friction movement [10, 15, 17, 81].  Cartilage is unique in its matrix 
structure and biomechanical properties, but like several other highly differentiated 
tissues has poor regenerative capabilities in mammals after structural injuries.  A limited 
amount of repair can occur in articular cartilage lesions that extend into the subchondral 
bone (full thickness defects), wherein mesenchymal cells from the bone marrow migrate 
into the lesion and lay down a fibrocartilaginous repair tissue.  However, this repair 
tissue is structurally and functionally inferior to normal articular cartilage and has low 
durability over longer terms.  Somewhat paradoxically, the repair capacity is even less 
for partial thickness defects.  Without the extension of a lesion into the subchondral 
bone, marrow-derived mesenchymal cells are blocked from participating in the repair 
process [8, 10, 11].  There are some data to suggest that repair of partial thickness 
lesions is possible in fetal and neonatal mammals, but the capacity is not retained in the 
postnatal period [82, 83].  Numerous and varied treatment approaches ranging from 
nutritional supplements, medications, surgical debridement, mesenchymal stem cell 
therapy, and tissue engineering, have been developed and prescribed.  However, clinical 
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outcomes consistently fall short of restoring normal structure and function to synovial 
joints [4, 8, 11, 84-87].  The ultimate therapeutic goal would be to generate a hyaline 
cartilage repair tissue that is structurally and biomechanically identical to normal 
articular cartilage.  Unfortunately, incomplete repair often results in progressive 
cartilage deterioration over time resulting in degenerative joint disease and 
osteoarthritis.  Morbidity of degenerative joint conditions is high in all mammals and it is 
a leading cause of retirement from athletic careers and even cessation of previously 
routine activities due to joint pain and decreased mobility [9, 84, 88].  
The Mexican axolotl salamander (Ambystoma mexicanum) is a promising model 
system for studies on cartilage repair due to a remarkable ability of these amphibians to 
regenerate amputated limbs and heal even large joint lesions.  Experiments done in our 
laboratory were the first to demonstrate that axolotls will completely repair large 
intrinsic articular cartilage defects.  This capacity was studied in the femoro-tibio-fibular 
(knee) joints, which interestingly retain interzone tissue in the intra-articular space and 
remain non-cavitated even through adulthood.  Based on histological assessments of 
the repair process, interzone cells proliferate and extend into lesions generating a 
primary repair tissue that then differentiates to restore normal tissue structures [79].  If 
the interzone tissue is surgically ablated, however, normal tissue structures are not 
restored and the joint fuses (arthrodesis, unpublished observation).   
An additional assessment of interzone tissue’s differentiation potential in axolotls 
was achieved through grafting experiments into critical sized defects created surgically 
in the tibia diaphysis.  Interzone tissue achieved closure of the defect, but rather than 
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yielding diaphyseal bone, an entirely new joint was formed de novo complete with 
apposing articular surfaces and intervening interzone.  In contrast, skin and muscle 
tissue transplants failed to bridge the skeletal defect in the tibia diaphysis.  Cell tracking 
analysis by GFP immunostaining confirmed that cells within the new diarthrodial joint 
were indeed derived from the GFP transgenic donor interzone cells [80].   
The importance of the interzone as a developmental tissue in synovial joint 
formation is well established [47-49, 77, 89].  The studies described above, however, 
suggest that interzone cells also have the potential to spontaneously differentiate into 
multiple synovial joint tissues in a repair context.  Important issues that remain 
unknown, however, include the cellular and molecular mechanisms regulating this 
repair process.  Are cellular differentiation events orchestrated autonomously by the 
transplanted interzone cells or are they dependent on the skeletal microenvironment, 
or perhaps both?  The hypothesis tested in this study was that de novo joint formation 
by interzone cells in the tibial CSD is mediated in part by a skeletal microenvironment. 
 
Materials and methods 
Animals 
A total of 40 axolotl salamanders (1.5 years of age), progeny of a single genetic 
cross and purchased as fertilized eggs from the Ambystoma Genetic Stock Center 
(University of Kentucky, Lexington, KY), were maintained at 20-22°C in 25% Holtfreter’s 
solution [90].  Animal care and management was carried out as previously described 
[79, 80].  All procedures were conducted in accordance with the guidelines of an 
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approved University of Kentucky Institutional Animal Care and Use Committee protocol 
(IACUC #2008-0282).  
 
Surgical procedure 
Interzone tissue samples were collected immediately postmortem.  Donor 
salamanders (n=20) were deeply anesthetized with 0.01% Benzocaine solution (w/v, 
Sigma, Cat# E1501, St. Louis, MO) in 25% Holtfreter’s solution and euthanized by 
cervical dislocation.  Interzone tissue was dissected from both the right and left 
femorotibial joints of germline GFP transgenic individuals using a 3 mm micro-sharp 
blade (Cat# 377513, Beaver-Visitec International, Waltham, MA) under a dissection 
microscope.  Careful attention was paid to avoid inclusion of any attached articular 
cartilage with the dissected interzone sample.  
Harvested interzone tissue samples were immediately transplanted into either 
skeletal or non-skeletal sites in wild type (non GFP transgenic) recipient individuals 
(n=20), depicted in Figure 2.1.  A surgical plane of anesthesia was achieved by 
immersing recipient axolotls in 0.01% benzocaine solution and then sustained by 
keeping them wrapped in paper towels soaked with either the same benzocaine 
solution or only 25% Holtfreter’s solution depending on the depth of anesthesia.  
Keeping the salamanders moist during surgery also facilitated oxygen exchange and 
prevented drying of the skin.  For the skeletal site transplant, a 5-6 mm skin incision was 
made over the tibia, which was then exposed by blunt dissection of soft tissues using 
micro forceps.  A 4 mm long centrally positioned fragment of the tibia diaphysis was 
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then excised and a GFP interzone transplant sample placed into the defect without 
consideration of orientation.  For the non-skeletal site, a pocket was made in the 
hepatic falciform ligament by folding it upon itself.  Harvested interzone tissue was then 
placed in the falciform ligament pocket with closure secured using nylon 6-0 purse string 
sutures (Ethicon, Cat# 37098, Somerville, NJ).  Finally, skin incisions were closed with 6-0 
vicryl suture (Ethicon, Cat# D5890, Somerville, NJ).  Following surgery, recipient 
individuals were recovered in Holtfreter’s solution.  All salamanders were monitored 
daily throughout the period of study for post-operative complications and to assess 
their ability to maintain mobility of the operated limb.  
 
 
 
Sample collection and processing  
Experimental samples were collected from five recipient wild-type salamanders 
at 2, 6, 18 and 30 weeks after surgery as outlined in Table 2.1.  Axolotls were deeply 
anesthetized with 0.01% Benzocaine solution in 25% Holtfreter’s solution and 
Figure 2.1: Anatomical location of the skeletal and non-skeletal site for interzone 
transplantation. 
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euthanized by transection of the cervical spinal cord.  Interzone transplants and 
surrounding tissues were collected at each time point and fixed in 4% paraformaldehyde 
in phosphate buffered saline (PBS) for 48 hours.  Samples containing skeletal elements 
were decalcified in 15-20X volume of Ethylenediaminetetraacetic acid (EDTA) and 
hydrochloric acid (Cat# 22-050-130, Richard Allen Scientific, Kalamazoo, MI) with 
periodic testing to assess the progress of decalcification.  Decalcification was considered 
complete by a lack of precipitate formation in the test solution to indicate calcium 
leaching from the skeletal tissues.  The samples were then transferred to 70% ethanol 
prior to paraffin embedding.  All samples were sectioned at 5 µm.  
 
Histology and immunohistochemistry 
Hematoxylin and Eosin (H&E) staining was performed using standard protocols.  
Safranin-O/Fast Green staining was optimized and standardized for axolotl samples 
using aqueous 1% Fast Green and 0.05% Safranin-O solutions as previously described 
[79, 80].  
Immunohistochemistry was used to assess the expression of GFP.  
Immunostaining was performed using standard avidin biotin complex reagents and 
methods according to the manufacturer’s protocol (Santa Cruz Biotechnology, Cat# SC 
2051 Santa Cruz, CA).  All sections were pretreated with 3% hydrogen peroxide to 
quench endogenous peroxidase activity.  Sections stained for GFP were pretreated to 
enhance antigen retrieval with a 0.2 M sodium citrate buffer, pH 3.5, for 20 minutes at 
37C.  For the primary antibody, polyclonal rabbit anti-GFP IgG (Abcam, Cat# AB290, 
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Cambridge, MA) was diluted at 1:1500.  Sections were then incubated for 30 minutes 
with the supplied pre-diluted biotinylated secondary antibody followed by detection 
using the HRP-streptavidin system.  All sections were counterstained with Gill No. 3 
hematoxylin (Sigma, Cat# HS316).  
 
Results  
Skeletal site interzone transplants 
Transplanted interzone tissues at skeletal sites were successfully recovered from 
all the individuals at the defined post-surgical time point (Table 2.1).  The size and 
location of the CSD in the tibia diaphysis was confirmed at 2 weeks (Figure 2.2A, 2.3A, 
2.4A).  By 6 weeks post-surgery, cartilaginous caps were apparent at the transected 
bone ends of the tibia (Figure 2.2B) that showed positive proteoglycan staining with 
Safranin O (Figure 2.3B).  GFP immunohistochemistry demonstrated an absence of 
staining in the cartilage outgrowths, but positive staining in the donor interzone tissue 
within the tibial bone defect (Figure 2.4B).  By 18 weeks, columns of proteoglycan 
expressing tissue were observed at the skeletal site which appeared to progress from 
the cartilage caps at the both the proximal and distal cut ends of tibia towards the 
middle of the gap fracture (Figure 2.2C, 2.3C).  Cells within this new cartilaginous 
outgrowth stained positive for GFP by immunohistochemistry (Figure 2.4C) confirming 
an origin from the interzone transplant.  Formation of a de novo diarthrodial joint was 
apparent at 30 weeks and appeared to follow normal spatial patterning.  Specifically, 
the new accessory joints were comprised of an interzone-like tissue between two 
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proteoglycan expressing cartilaginous structures.  In addition, cellular morphological 
features in the new cartilage appeared similar to normal epiphyseal/articular and 
metaphyseal chondrocytes (Figure 2.2D, 2.3D).  Cells within the newly formed 
diarthrodial joint stained positive for GFP by immunostaining, including the interzone-
like tissue and a subset of the adjacent chondrocytes.  In contrast, cells within the repair 
tissue positioned closer to the original ends of the tibia demonstrated negative GFP 
staining comparable to controls (Figure 2.4D-H).  Regions of GFP positive cells did exhibit 
asymmetry proximal and distal of the new interzone layer.  However, there was no 
evidence to suggest a migration of the transplanted interzone cells outside the tibial 
skeletal defect.  These observations are broadly consistent with previous findings [80].  
 
 
 
 
 
Table 2.1: Experimental samples - Biological replicates, post-surgical collection time and 
incidence of recovery of skeletal and non-skeletal interzone tissue transplant.     
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Figure 2.3: Repair of critical sized bone defects (skeletal) with interzone tissue transplants. Safranin-O 
stained sections are shown at 2,6,18, and 30 weeks post-surgery (A-D, respectively). At 30 weeks (D), the 
defect is closed with formation of a new joint.  All images are at 4x (objective lens) magnification. 
Figure 2.2: Repair of critical sized bone defects (skeletal) with interzone tissue transplants. H&E stained 
sections at 2,6,18, and 30 weeks post-surgery (A-D, respectively). At 30 weeks (D), the defect is closed 
with formation of a new joint.  All images are at 4x (objective lens) magnification. 
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Figure 2.4: Repair of critical size bone defects with interzone tissue transplants. GFP immunostaining 
at 2,6,18, and 30 weeks post-surgery (A-D, respectively). At 30 weeks (D-F), cells within the accessory 
joint show positive immunostaining for GFP suggesting their origin from the transplanted interzone 
cells. Positive (G) and negative (H) controls for GFP immunostaining.  A-D and G-H are at 4x, E-20x and 
F-40x (objective lens) magnification. 
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Non-skeletal site interzone transplants 
In contrast to the tibial surgical site, interzone tissue that was transplanted to 
the non-skeletal falciform ligament pockets were located post-surgically in only two 
salamanders (Table 2.1) This occurred even with placement of surgical markers at the 
transplant site in all recipients and careful assessment of serial sections.  For the two 
exceptions, both at the 6 week time point, the interzone transplant presented as a 
nondescript area of GFP expressing tissue (Figure 2.5C).  There was no evidence of 
chondrogenic differentiation and minimal proteoglycan expression.  However, a zone of 
basophilic cellular infiltration was apparent around the transplanted interzone tissue 
suggestive of an immune response against the allograft (Figure 2.5A, B and C (arrows)).  
 
 
 
 
Discussion  
The data presented in this chapter support the hypothesis that de novo joint 
formation by interzone cells in tibial CSDs is mediated in part by the skeletal 
microenvironment.  The first sign of repair in the gap fracture was formation of a 
Figure 2.5: Tissue response in the non-skeletal site to interzone tissue transplants. The transplanted interzone tissue 
remained intact in the non-skeletal site as revealed by H&E (A), Safranin-O (B) and GFP immunostaining (C). Cellular 
cuffing (arrows) around the transplant suggests an immune response against the allograft.  All images are at 10x 
(objective lens) magnification.  
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cartilaginous callus at the fractured bone ends that showed an absence of GFP 
immunostaining.  This rounding of the proximal and distal ends of the tibia with 
cartilage was also observed with control (non-interzone) skin and muscle transplants 
reported previously  [80] and appears to mimic the process of host-directed transverse 
fracture repair in mammals [91, 92].  Histological analysis of the skeletal defect with 
interzone transplants revealed the de novo formation of an accessory joint by 30 weeks.  
Positive proteoglycan expression and chondrocyte-like cell morphology were observed 
in the adjoining cartilaginous structures of the accessory joint.  Moreover, cells within 
the repair tissue stained positively for GFP by immunohistochemistry, confirming that 
they were derived directly from the interzone transplant tissue.  However, this GFP 
expression was limited to the subset of cells within the new layer of interzone and 
immediately adjacent cartilage.  The rest of the cells within the repair tissue that closed 
the gap fracture stained negative for GFP suggesting that they were derived from the 
recipient and not the transplant.  
The transplanted interzone tissue was placed in a random orientation within the 
CSD, yet at 30 weeks, the repair tissue had clearly developed a level of structural 
organization.  The neo joint resembled the architecture of the normal diarthrodial joint 
with a layer of interzone tissue between two cartilaginous structures that displayed 
cellular morphologies similar to epiphyseal/articular chondrocytes and metaphyseal 
chondrocytes.  The findings suggest a multifaceted role for the interzone cells in skeletal 
repair – the ability to self-renew to maintain an interzone cell population and the 
potential to differentiate into cartilaginous cell types.  This differentiation profile is 
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similar to the normal developmental function of interzone cells in mammalian joints [48, 
74, 77].   
In contrast, the non-skeletal falciform ligament microenvironment did not appear to 
support the transplanted interzone tissue.  One possible explanation for the inability to 
locate the transplants in a majority of the experimental samples is immune rejection by 
the recipient.  This argument is strengthened by the basophilic cellular cuffing observed 
around the transplanted tissue and is consistent with previous reports of immune 
response against allotransplants in related amphibians [93, 94].  In the only two samples 
where the interzone transplant could be located, there was no evidence of 
chondrogenic differentiation.  
Taken together, these results raise the question as to why interzone cells were able 
to proliferate and differentiate in the tibial CSD but not in the falciform ligament pocket.  
One possible reason for this differential response could be qualitative and/or 
quantitative differences in localized growth factor production between the two sites.  
The critical sized defect in the tibia diaphysis may have been subjected to more local 
trauma from the surgical procedure.  Such a lesion could be expected to take longer to 
heal.  This provides an extended period of time with localized growth factor production 
to aid the repair process which could also have a positive trophic effect on the 
transplanted interzone cells.  In contrast, the degree and duration of stimulation by 
localized growth factors in the non-skeletal site could be limited owing to lower trauma 
and rapid tissue repair.  The possibility that the diaphyseal surgical site is 
immunologically privileged cannot be ruled out in the current study, but is not reported 
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in the literature.  The data support a model whereby the interzone transplants respond 
to paracrine inductive signals from the skeletal environment to proliferate and 
differentiate into multiple cell types.  Further investigation of paracrine mechanisms 
that regulate interzone cell proliferation and differentiation in a skeletal 
microenvironment may provide new insight into the potential of interzone for cell-
based therapy for the repair of synovial joint defects involving the articular surface.   
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Chapter 3 
Effect of skeletal paracrine signals on the proliferation of interzone cells 
 
Introduction  
Interzone cells demarcate the presumptive site of synovial joint development in 
mammalian and avian embryos, initially appearing as a compact layer of mesenchymal 
cells which down regulate the expression of chondrocyte-specific type II collagen and up 
regulate a new set of genes including GDF5, WNT4, WNT9A and type I collagen [2, 7, 49, 
78].  Elegant lineage tracing studies in mice indicate a role for the GDF5 positive 
interzone cells in the formation of articular cartilage, synovial membrane, and 
associated joint structures during development.  Just prior to cavitation of the joint, the 
interzone can be appreciated as a tripartite structure with a cell-dense intermediate 
layer and two outer layers with comparatively low cellularity [48, 89].  These authors 
suggest distinct fates for the two layers of the interzone.  Cells in the outer zone 
contribute secondarily to the epiphyseal anlage chondrocytes that subsequently 
undergo endochondral ossification and replacement by bone while the intermediate 
zone forms the articular tissues, including cartilage.  More recently, gene expression 
analyses of the intermediate and outer zones of murine embryonic interzone has 
provided additional evidence to support the view that cells in the interzone are the 
developmental progenitors of tissues in diarthrodial synovial joints [77].  
Experiments with axolotl salamanders in our laboratory were the first to indicate 
that interzone cells have the potential to repair articular cartilage lesions [79, 80].  My 
30 
 
experiments, described in Chapter 2, support these findings and further demonstrate 
that the skeletal microenvironment supports interzone cells and promotes their ability 
to repair critical sized bone defects.  The repair tissue that bridged the bone gap in these 
studies matured to an anatomically organized structure resembling an intact joint with 
an interzone layer positioned in between two cartilaginous zones of tissue.  The newly 
formed cartilage included cells with morphological features very similar to both 
epiphyseal/articular and metaphyseal chondrocytes.  In contrast, interzone tissue 
transplanted into a non-skeletal site failed to thrive and appeared to be rejected or 
resorbed.   
The observation that interzone transplants placed in a random orientation within a 
skeletal defect develop into an accessory joint with the correct spatial patterning of the 
tissues is particularly interesting.  It suggests that some form of cellular communication 
and regulation is occurring.  One possibility is paracrine signals between skeletal cells of 
the recipient salamander and the transplanted interzone cells stimulating both self-
renewal to maintain the interzone pool and chondrogenic differentiation to generate 
the cartilaginous tissues that form the new accessory joint.  Moreover, this process 
might be governed by highly dynamic spatio-temporal patterns of gene expression, 
recapitulating embryogenic developmental events [95-97].  Unfortunately, technical 
challenges that limited our ability to culture primary amphibian cells precluded further 
studies with the axolotls.   
In this chapter, we report establishing a mammalian in vitro co-culture model to 
examine a potential paracrine interaction between skeletal cells and the interzone.  
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Medium used to maintain cells in culture can be expected to accumulate the cells’ 
secretome during incubation [98] and is referred to as conditioned medium.  This 
medium ‘conditioned’ by the signal producing cells can be added exogenously to a 
second culture to assess an impact of cell-secreted factors on the signal receiving cells 
[99-105].   
The experiments reported in this chapter were designed to test the hypothesis that 
paracrine signals derived from skeletal cells stimulate interzone cell proliferation 
employing skeletal cell-derived conditioned medium as the source of paracrine mitotic 
stimuli.  The mitogenic potential of skeletal cells could differ with age of the individual 
from whom the cells were derived, with embryonic cells expected to exhibit a higher 
proliferative potential compared to those of adult origin [106].  This study also examines 
an effect of donor age on the ability of skeletal cells to induce proliferation of interzone 
cells. 
 
Materials and methods 
Isolation and culture of cells  
Methods utilized for the isolation of equine tissue samples and the preparation of 
primary cell lines that were used in this project have been described previously [107].  
Mares were bred by natural cover after estrous cycle synchronization with two doses of 
intramuscular synthetic prostaglandin F2α (500 µg of cloprostenol sodium, Estrumate©) 
given 14 days apart.  A stallion was placed in the pasture for 10 days with the mares.  
Serum progesterone levels of the mares were monitored daily leading up to the 
32 
 
approximate date of ovulation, which was called day 0 of gestation if the mare was 
determined to be pregnant.  Gestational age was confirmed six days after the stallions 
were separated from the mares (16 days after the mares were programmed to ovulate) 
through a transrectal ultrasound examination to determine embryonic vesicle size [108].   
Fetuses were recovered intact at 45 or 46 days of gestation from mares (one 
fetus per mare) while standing and sedated using a minimally invasive uterine lavage 
technique.  Prior to collection, the mare’s pregnancy status was reconfirmed by 
transrectal ultrasonography.  The vulva and perineal area were cleaned aseptically, and 
2 mg of synthetic prostaglandin E2 paste (in 2.5 ml triacetin and 125 mg silicon dioxide 
gelling agent) instilled along the length of the cervical ostium after gentle and minimal 
digital dilation. One hour later, the mares were sedated with detomidine (10 – 16 µg/kg 
IV) and butorphanol (6 – 16 µg/kg IV).  The cervical ostium was digitally dilated per 
vagina aseptically and a 28 mm OD endotracheal tube was positioned to the level of the 
internal ostium of the cervix.  The uterus was lavaged following introduction of 2-3 liters 
of warmed sterile lactated Ringers’ solution, including the gentle balloting of the fluid 
filled uterus per rectum.  This readily displaced the embryo within its vesicle, which was 
then recovered into a sterile bag by gravity evacuation of the lavage fluid back through 
the tube.  In all cases, great care was taken to ensure passage of the fetal membranes.  
Immediately after collection, fetuses were thoroughly rinsed in ice cold sterile 
Dulbecco’s phosphate buffered saline (PBS; Gibco, Cat# 14190144) with 2% (v/v) 
amphotericin B (anti-mycotic, Gibco, Cat# 15290026) and 2% (v/v) 
penicillin/streptomycin (antibiotic; Gibco, Cat# 15070063).  Each fetus was catalogued 
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and transported in a sterile container on ice for immediate tissue processing.  After the 
procedure, each mare was given two doses of 500 µg of cloprostenol sodium 
(Estrumate©, synthetic prostaglandin F2α) as an intramuscular injection spaced 24 
hours apart to facilitate complete uterine clearance.  Mares also received a single dose 
of flunixin meglumine (1 mg/kg IV, non-steroidal anti-inflammatory).  
All procedures were conducted in accordance with a University of Kentucky 
institutional animal care and use protocol (IACUC #2014-1215).  The mares from which 
fetuses were collected did not suffer any observed post-harvest complications or health 
issues.  
 
Fetal cell lines 
Interzone cells and anlage chondrocytes were isolated from one forelimb and 
one hind limb of each fetus.  Skin and developing soft tissues over the limb skeletal 
elements were carefully removed using a dissecting microscope and sterile instruments.  
Interzone cells were liberated from the cuboidal bone anlage of developing carpal and 
tarsal joints by digestion in 500 µl of commercial 0.25% trypsin EDTA solution (Gibco, 
Cat# 25200056) for 5-10 minutes with gentle agitation using a micropipette.  The 
enzymatic activity of trypsin was then quenched with 1 ml Dulbecco’s Modified Eagles 
Medium (DMEM, Gibco, Cat# 10569044) supplemented with 10% (v/v) heat inactivated 
fetal bovine serum (FBS), 1% (v/v) P/S, and 1% amphotericin B (FBS medium).  The 
undigested tissue fragments and the cuboidal bones were allowed to settle by gravity 
for 3 minutes.  The supernatant containing the suspended cells was then transferred to 
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a sterile 15 ml polypropylene tube, and centrifuged at 1000 rpm for 3 minutes.  The 
resulting pellet was re-suspended in 5 ml of FBS medium, and plated in six well cell 
culture plates (Bio-Star, VWR Cat# 10062-892).  Collagenase was not used in the 
isolation of interzone cells to prevent contamination from liberated anlage 
chondrocytes.  Anlage chondrocytes were isolated from internal cubes dissected from 
distal metaphyseal anlage of the developing humerus and femur with careful attention 
to avoid inclusion of the epiphysis, diaphysis, or anlage surface.  To further minimize the 
potential for cell contamination, the anlage cubes were incubated in 500 µl of the 
commercial 0.25% trypsin EDTA solution for 5-10 minutes, followed by gravitational 
settling of the anlage cubes.  This was followed by two rinses in sterile Dulbecco’s 
phosphate buffered saline supplemented with 2% (v/v) P/S, and 2% (v/v) amphotericin 
B.  Chondrocytes were then liberated from the matrix using 1 ml of 0.5% collagenase D 
(Worthington, Cat# CLS4; http://www.worthington-biochem.com/cls/pl.html) for 10-20 
minutes with gentle agitation using a micropipette.  Quenching of the collagenase 
enzyme activity, isolation and plating of primary anlage chondrocytes were performed 
in a similar fashion as described above for interzone cells.  Fibroblasts were isolated 
from the truncal dermis targeting a region of skin located away from any skeletal 
structures.  Care was taken during tissue dissection to ensure exclusion of epidermis and 
hypodermis.  The subcutaneous dermal tissue was then finely minced, followed by 
digestion in 1 ml of the commercial 0.25% trypsin EDTA solution for 10-20 minutes with 
gentle agitation using a micropipette.  Separation of undigested tissues, quenching of 
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enzyme activity, isolation, and plating of primary dermal fibroblasts were similar to the 
procedures described above for interzone and anlage chondrocytes.  
 
Adult cell lines  
Tissue samples were collected immediately postmortem from six young adult 
horses of mixed light breed heritage that were euthanized at 15-17 months of age for 
reasons unrelated to the current study (IACUC 00843A2005).  Bone marrow aspirates 
were collected from the sternum using an 8 FrG Jamshidi needle and heparinized 
syringes [109].  The samples were stored on ice until processing, which involved direct 
plating in 1:1 FBS medium in T-75 tissue culture flasks (Bio-Star, VWR Cat# 82050-856).  
The cultures were rinsed with PBS over the course of the first few days of culture to 
facilitate removal of red blood cells and yield adherent cells. 
Dermal fibroblasts were isolated from the dermal layer of skin at the tail base.  
Dermis was minced and transferred to tissue culture plates in FBS medium.  Dermal 
tissue explants were maintained in FBS medium for several days to yield adherent 
dermal fibroblasts.  The processing of bone marrow and dermal tissue samples were 
completed within three hours post-mortem.  
Articular chondrocytes were isolated as previously described [110].  Briefly, 
articular cartilage of the femoro-tibial joint was shaved down to the calcified layer.  
Cartilage shavings were copiously rinsed in PBS with 2% antimycotic and antibiotic 
supplements as above.  The shavings were minced, weighed, and digested for 22 hours 
in medium (OptiMEM [Gibco Cat # 51985091, 5% FBS, 1% antimycotic/antibiotic) 
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containing bacterial collagenase (Worthington) at 7.5 mg collagenase/g of cartilage. 
Primary chondrocytes released from the cartilage matrix were centrifuged, rinsed, 
counted, and plated into T-75 tissue culture flasks at a seeding density of 2.1 x 106 cells 
per flask.  
A total of 6 primary cell lines isolated from five equine fetuses and five young adult 
horses were used for this study.  Each biological replicate provided all three fetal or all 
three adult cell lines, respectively. 
1. Adult articular chondrocytes (AEC) 
2. Adult bone marrow derived cells (BM) 
3. Fetal anlage chondrocytes (FEC) 
4. Fetal interzone cells (IZ) 
5. Adult dermal fibroblasts (AEF) 
6. Fetal dermal fibroblasts (FEF) 
 
Conditioned medium preparation 
The six primary cell lines isolated from skeletal and non-skeletal tissues of equine 
fetuses (n=5) and adult horses (n=5) were used for the preparation of conditioned 
medium.  To prepare the conditioned medium, thawed P2 cells were passaged and 
plated at P3 into five T-75 tissue culture flasks at a seeding density of 500,000 cells per 
flask in FBS medium.  Medium was replenished every 48 hours until the cells reached 
70-80% confluence.  The cells were then rinsed thrice with PBS, and incubated for 24 
hours in 5 ml of DMEM supplemented with 1% (v/v) P/S, and 3 mg/ml of bovine serum 
Skeletal cells 
Non-skeletal cells 
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albumin (BSA; Sigma Cat# A9418; BSA Medium).  This amount of BSA was calculated to 
be roughly equivalent to the amount of total protein in 10% FBS.  In control 
experiments, 24 hours of conditioning was found to elicit a greater mitogenic response 
with adult dermal fibroblasts in comparison to medium conditioned for 72 hours (data 
not shown).  At the end of the incubation period, the media from the five T-75 flasks 
were pooled for each cell type and each biological replicate, centrifuged, sterile filtered 
using a 0.2 µM Polyethersulfone membrane filter (VWR, Cat # 28145-501), and stored at 
-80C in aliquots.  For normalization, cells from each corresponding group of five T-75 
flasks were trypsinized and counted, and the total cell count that generated the volume 
of conditioned medium was recorded and used throughout this study.  
 
Co-culture 
Background proliferation  
To minimize background cell proliferation in the experimental system prior to 
assessing the mitogenic activity of the conditioned medium, a determination was made 
on growth arresting the P3 cells through FBS deprivation to the point where the rate of 
cell division approached zero but cell viability remained high.  This was determined 
empirically for each cell line studied.  P3 cells were plated in FBS medium for 24 hours 
after which the medium was replaced with BSA medium.  The cells were maintained in 
this serum-deprived state, with viability and proliferation assessments performed as 
described below every 48 hours.  BSA medium was also re-fed at 48 hour intervals.  The 
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functional ability of the serum starved cells to respond to mitogenic stimuli was then 
evaluated by re-feeding with FBS medium.  
Sample size was determined by power analysis.  Power calculations were 
performed using data from a pilot study (Table 3.1) to assess interzone cell proliferation 
in response to conditioned medium from fetal skeletal and non-skeletal cell lines (n=2) 
using the following equation: 
∅ = � 𝑟𝑟
𝑀𝑀𝑀𝑀𝑀𝑀
�
𝜏𝜏𝑖𝑖
2
𝑡𝑡
 
 
where 𝑟𝑟  is the number of randomized complete blocks, t is the number of treatments, 
MSE is the mean squared error and 𝜏𝜏𝑖𝑖2 is the square of the differences of each block and 
the overall mean for the treatment.  The estimated sample size required to achieve a 
power of 0.80 was two.  The number of biological and technical replicates used in this 
study is outlined in Table 3.2 and 3.3. 
 
Differential production of mitogens  
The first part of the experiments reported in this chapter compared the level of 
interzone cell proliferation stimulated by conditioned medium derived from six different 
skeletal and non-skeletal primary cell lines.  The different preparations of conditioned 
medium were prepared as described above and considered as the source of paracrine 
signals.  Interzone cells were kept constant as the responder cells.  A summary of 
biological and technical replicates used is presented in Table 3.2.  
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Table 3.2: Differential production of mitogens – Description of biological and technical replicates in 
experimental and control groups.  Biological replicates here represent the equine fetuses or adult horses 
from which primary cells were isolated and the individual wells of the 24 well culture plate represent the 
technical replicates.  The sample size was determined by power analysis.  
Table 3.1: Table showing the mean and standard deviation of percent change in proliferation of interzone 
cells in control and conditioned media from fetal dermal fibroblast (FEF-CM), Fetal anlage chondrocytes 
(FEC-CM), and Fetal interzone cells (IZ-CM). 
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Interzone cells at P3 were plated in 24 well plates in FBS medium at a seeding 
density of 50,000 cells per well to yield an adherent monolayer.  Following 24 hours of 
culture, the medium was replaced with BSA medium for 5 days (experimental time point 
for interzone cells) to minimize the level of background proliferation.  On day 5, the 
interzone cell monolayers were re-fed with either conditioned medium derived from 
one of the experimental cell lines, BSA medium as a negative control, or FBS medium as 
a positive control. 
 
Differential cellular response to the same level of mitogenic stimuli  
The second set of the experiments reported in this chapter focused on 
determining whether any of the cell types exhibit a differential response to the same 
level of mitogenic stimulation.  As such, the six primary cell lines isolated from equine 
fetuses and adult horses were evaluated independently as responders, while the stimuli 
from conditioned medium prepared from fetal anlage chondrocytes was held constant.  
A summary of the biological and technical replicates is outlined in Table 3.3.  Plating and 
co-culture for all the cell lines were performed as described above. 
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Assessment of cell viability  
Cell viability was assessed using a commercial LIVE/DEAD Viability/Cytotoxicity 
Kit for mammalian cells (ThermoFisher Scientific, Cat# L3224) according to the 
manufacturer’s protocol.  Briefly, adherent cells in 24 well plates were washed twice 
with PBS to remove residual serum esterase activity.  The cytoplasm of live cells stains 
with Calcein AM (1 µM), while nuclei of dead cells stain with ethidium homodimer-1 (2 
µM).  All cell nuclei were counterstained with Hoechst 3342 (5 mg/ml) (ThermoFisher 
Scientific, Cat# 3570).  The total number of cell nuclei and the dead cell nuclei per field 
were counted using automated imaging software (NIS elements 4.0, Nikon Instruments 
Inc.) and the percent viability was calculated as the number of live cells per 100 cells 
total.  The counts were recorded in 3 distinct fields and averaged for each well. 
 
 
Table 3.3:  Differential cellular response to the same level of mitogenic stimuli – Description of 
biological and technical replicates in experimental and control groups.  Biological replicates here 
represent the equine fetuses or adult horses from which primary cells were isolated and the 
individual wells of the 24 well culture plate represent the technical replicates.  The sample size 
was determined by power analysis. 
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Assessment of cell proliferation 
Levels of cell proliferation were quantified by measuring the incorporation of 5-
ethynyl-2'-deoxyuridine (EdU) following a pulse labeling.  EdU is a thymidine analog that 
is efficiently incorporated into newly synthesized DNA and can be fluorescently labeled 
to visualize those cells that have progressed through the synthesis (S) phase of the cell 
cycle.  EdU incorporation and subsequent visualization were performed as described 
previously [111].  Briefly, cells were labeled with a 24 hour pulse of EdU (Jena 
Bioscience, Cat# CLK N001-25) at a concentration of 8 µM.  The cells were then fixed in 
4% paraformaldehyde in PBS prior to permeabilization with 0.1% Triton-X followed by 
detection.  For detection of the EdU label, the cells were incubated for 30 minutes in 
100 mM Tris, 4 mM CuSO4 (Sigma, Cat# 451657), 100 µM Biotin conjugated azide in 
DMSO (Jena Bioscience, Cat# CLK-AZ104P4-25), and 100 mM ascorbic acid (Sigma, Cat# 
451657).  The staining mix was prepared fresh for each assay and was used for staining 
cells immediately after the addition of ascorbic acid.  The EdU label was visualized with 
streptavidin-conjugated Texas Red (Vector Biolabs, Cat# SA 5006).  The cells were 
counterstained with DAPI (4′, 6-diamidino-2-phenylindole; Life Technologies, Cat# 
D1306).   
The total number of cell nuclei and the number of proliferating cells (EdU 
labeled) were counted using automated imaging software (NIS elements 4.0, Nikon 
Instruments Inc.) by fluorescence microscopy.  The rate of proliferation was calculated 
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as the number of EdU labeled cells as a percent of the total number of cells in each field.  
The percent proliferation was calculated for 3 fields per well and the values averaged. 
 
Statistical analysis 
Data from the viability and proliferation assays were independently evaluated by 
one-way analysis of variance.  Medium type (conditioned and control media) was the 
factor being tested at the following levels – Conditioned medium from Fetal dermal 
fibroblasts (FEF-CM), Fetal anlage chondrocytes (FEC-CM), Fetal interzone cells (IZ-CM), 
Adult dermal fibroblasts (AEF-CM), Adult articular chondrocytes (AEC-CM) and Bone 
marrow derived cells (BM-CM), negative control (BSA medium), and positive control 
(FBS medium).  Pair-wise comparisons were made between the different levels with a 
Bonferroni post hoc correction for multiple comparisons.   
Differences were considered statistically significant if the corrected p-value was 
<0.005.  Age of the donor from which primary cells were isolated was evaluated as an 
additional factor.  Residual plots, histograms of residuals and Q-Q plot of residuals were 
evaluated to ensure that the normality assumptions were not violated.   
 
Results 
Background proliferation – The amount of time in BSA medium to achieve a minimal 
level of background proliferation in culture was identified for each cell line empirically.   
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They are as follows: 
1. Adult articular chondrocytes   
2. Adult bone marrow derived cells  
3. Fetal anlage chondrocytes 
4. Fetal interzone cells 
5. Fetal dermal fibroblasts 
6. Adult dermal fibroblasts  
 
The cell lines were then evaluated for 10 days after re-feeding with FBS medium.  In 
each case, the 48 hours post-treatment exhibited the maximum percentage of 
proliferating cells likely due to synchronization of the cell cycle.  Cell viability was 
supported by re-feeding with FBS medium, but remained above 94% even in cells 
maintained in BSA medium.  Figure 3.1 illustrates data from interzone cells, but is 
representative of all six cell lines.  
  
 
 
 
Day 5 
Day 7 
Day 3 
Figure 3.1: Time course study to identify point of minimal background proliferation for interzone cells - 
Change in cell proliferation (A) and viability (B) of interzone cells after feeding with FBS medium (red) on day 5 
(arrow) compared to those maintained in the BSA medium (blue) throughout culture.   
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Differential production of mitogens   
Proliferation 
The level of proliferation was determined by measuring the number of cells that 
incorporated the EdU label as a percent of the total number of cells.  Figure 3.2 shows 
representative images of proliferating interzone cells (48 hours post-treatment) in 
response to medium conditioned by the different fetal cell lines.  Figure 3.3A and 3.3B 
demonstrate the overall change in percent proliferation in each experimental group 
over the time course of the study and specifically 48 hours post-treatment respectively.  
The percent proliferation trend in the fetal cell conditioned media was as follows: FBS 
medium > Fetal dermal fibroblast CM = Fetal anlage chondrocyte CM > Interzone cell 
CM > BSA medium.  Interzone cells in the positive control medium exhibited the highest 
percent proliferation, approaching 100% in all the experiments.  In contrast, the 
interzone cells in the negative control group had the smallest number of positively 
stained cells and lowest rate of proliferation.  All conditioned media groups generated a 
significantly higher mitogenic response in interzone cells relative to the negative control 
medium.  There was no significant difference in the percent proliferation values of 
interzone cells in fetal dermal fibroblast (FEF – CM) and anlage chondrocyte (FEC – CM).  
However, some variation was observed in the mitogenic induction ability within the FEC 
CM group compared to other groups (Figure 3.3 and Table 3.4).  Interestingly, interzone 
cell conditioned media (IZ – CM) was the least mitogenic among all the groups, but still 
stimulated cell proliferation at a level significantly higher than the negative control 
medium (p<0.001).   
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Interzone cells cultured with conditioned medium from all three types of adult cells 
exhibited significantly higher mitogenic activity than the negative control medium 
(Figure 3.4 and Table 3.4).  Interzone cells in positive control and negative control 
medium showed the maximum and minimum percent proliferation values respectively.  
The bone marrow derived cell conditioned medium (BM – CM) showed significantly 
higher mitogenic potential compared to adult chondrocyte (AEC – CM) and dermal 
fibroblast (AEF – CM) conditioned medium.  The difference in percent proliferation 
values of interzone cells in AEC – CM and AEF – CM did not reach statistical significance 
(p=0.0883).  
 
 
 
 
Figure 3.2:  Panel (10x) showing the proliferation of interzone cells in response to  fetal conditioned medium:                 
Edu – labeled proliferating cell nuclei (pink) and non-proliferating cell nuclei (blue) in positive control/FBS 
medium (A), negative control/BSA medium (B), Fetal dermal fibroblast (C), Fetal anlage chondrocyte (D), and 
fetal interzone (E) conditioned media.   
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Figure 3.3: Percent change in proliferation of interzone cells in response to control and fetal cell derived 
conditioned media over the time course of the experiment as a line graph (A) and at 48 hours post-
treatment as a box and whisker plot (B) Different letters indicate significant difference between treatment 
means from one-way ANOVA (p < 0.005). FEF-CM: Fetal dermal fibroblasts, FEC-CM: Fetal anlage 
chondrocytes, IZ-CM: Fetal interzone cells conditioned media, negative control (BSA medium) and positive 
control (FBS medium). 
Figure 3.4: Percent change in proliferation of interzone cells in response to control and adult  cell derived 
conditioned media over the time course of the experiment as a line graph (A) and at 48 hours post-
treatment as a box and whisker plot (B) Different letters indicate significant difference between treatment 
means from one-way ANOVA (p < 0.005). AEF-CM: Adult dermal fibroblasts, AEC-CM: Adult articular 
chondrocytes and BM-CM: Bone marrow derived cells conditioned media, negative control (BSA medium) 
and positive control (FBS medium). 
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Viability 
Cell viability was assessed by counting the number of live cells and was 
expressed as a percent of the total number of cells.  Interzone cells in the different fetal 
cell conditioned media and positive control medium showed significantly greater 
viability (>99%) relative to those in the negative control serum-free medium, which still 
retained cell viability at more than 95% (Figure 3.5, 3.6 and Table 3.5).  Interzone cells in 
the adult cell conditioned medium and positive control medium were significantly more 
viable compared to negative control medium.  In the experimental groups, there was 
Table 3.4: Table showing the mean and standard error values of percent change in 
proliferation in control and all experimental groups tested.  These data are presented 
graphically in Figure 3.3 and 3.4.  FEF-CM: Fetal dermal fibroblasts, FEC-CM: Fetal anlage 
chondrocytes, IZ-CM: Fetal interzone cells, AEF-CM: Adult dermal fibroblasts, AEC-CM: Adult 
articular chondrocytes and BM-CM: Bone marrow derived cells conditioned media, negative 
control (BSA medium) and positive control (FBS medium). 
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some variation in the percent viability (Figure 3.7 and Table 3.5).  However, it is worth 
noting that the lowest percent viability observed in our study was 94% indicating that a 
large majority of the cells remained viable within the time frame studied despite 
removal of FBS or another supplemental source of growth factors.    
 
 
 
 
 
 
 
Figure 3.5:  Panel (10x) showing the change in viability of interzone cells in response to positive control/FBS 
medium (A), negative control/BSA medium (B), Fetal dermal fibroblast (C), Fetal anlage chondrocyte (D), and 
fetal interzone (E) conditioned media. Cytoplasm of live cells appears green and dead cell nuclei stain red. All 
cells were counterstained with DAPI nuclear stain (blue). 
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Figure 3.6: Percent viability of interzone cells in response to control and fetal cell derived conditioned media 
over the time course of the experiment as a line graph (A) and at 48 hours post-treatment as a box and 
whisker plot (B) Different letters indicate significant difference between treatment means from one-way 
ANOVA (p < 0.005). FEF-CM: Fetal dermal fibroblasts, FEC-CM: Fetal anlage chondrocytes, IZ-CM: Fetal 
interzone cells conditioned media, negative control (BSA medium) and positive control (FBS medium). 
Figure 3.7: Percent viability of interzone cells in response to control and adult cell derived conditioned media 
over the time course of the experiment as a line graph (A) and at 48 hours post-treatment as a box and 
whisker plot (B) Different letters indicate significant difference between treatment means from one-way 
ANOVA (p < 0.005).  AEF-CM: Adult dermal fibroblasts, AEC-CM: Adult articular chondrocytes and BM-CM: 
Bone marrow derived cells conditioned media, negative control (BSA medium) and positive control (FBS 
medium). 
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Differential cellular response to the same level of mitogenic stimuli   
Proliferation 
The different cell lines demonstrated a positive but variable mitogenic response 
when exposed to the same conditioned medium.  Fetal dermal fibroblasts showed a 
significantly higher response compared to skeletal cell types.  Fetal anlage chondrocytes 
showed significantly lower percent proliferation relative to other fetal cell types (Figure 
3.8A).  The adult skeletal cell types showed lower percent proliferation relative to the 
non-skeletal dermal fibroblasts which demonstrated the greatest response to mitogenic 
stimuli comparable to that from serum containing FBS medium (Figure 3.8B).   
Table 3.5: Table showing the mean and standard error values of percent viability in control and all 
experimental groups tested. These data have been presented graphically in Figure 3.6 and 3.7. FEF-CM: 
Fetal dermal fibroblasts, FEC-CM: Fetal anlage chondrocytes, IZ-CM: Fetal interzone cells, AEF-CM: Adult 
dermal fibroblasts, AEC-CM: Adult articular chondrocytes and BM-CM: Bone marrow derived cells 
conditioned media, negative control (BSA medium) and positive control (FBS medium). 
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Discussion 
In this study, we examined how conditioned media, and thus, secreted paracrine 
signals from different cell lines, affected the proliferation and viability of interzone cells 
in co-culture.  A change in the rate of proliferation could be a function of the difference 
in the mitogenic stimuli that the cells are exposed to as well as how the same stimulus is 
perceived by different cell types.  Therefore, we assessed how the skeletal and non-
skeletal cell types respond differentially to the same mitogenic stimuli.  Additionally, we 
characterized an effect of donor age by comparing mitogenic potential of media 
conditioned by cells derived from equine fetuses and adult horses.  The findings from 
Figure 3.8: Box and whiskers plot representing the percent change in proliferation of fetal (A) and adult (B) cell 
types tested in response to fetal anlage chondrocyte conditioned medium at 48 hours post-treatment. Different 
letters indicate significant difference between treatment means from one-way ANOVA (p < 0.005). FEF: Fetal 
dermal fibroblasts, FEC: Fetal anlage chondrocytes, IZ: Fetal interzone cells, AEF: Adult dermal fibroblasts, AEC: 
Adult articular chondrocytes and BM: Bone marrow derived cells, negative control (BSA medium) and positive 
control (FBS medium). 
A B 
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this study support the hypothesis that skeletal cell-derived paracrine signals have a 
mitogenic effect on interzone cells.   
All experimental groups of conditioned media elicited a mitogenic response in 
interzone cells which fell between that from the positive and negative control media.  In 
the fetal group, FEC - CM and FEF - CM showed a significantly higher mitogenic potential 
compared to IZ - CM.  Among the adult cell conditioned media, BM - CM elicited a 
significantly higher response relative to AEC – CM and AEF - CM.  The amount of 
paracrine signals delivered to the interzone cells in this study was normalized by using a 
uniform period of incubation and volume of conditioned medium throughout the study.  
However, normalization was performed based on the cells that were trypsinized and 
counted from the tissue culture flasks after collection of conditioned medium.  This 
could contribute to the variation in mitogenic response that we observed in some of the 
experimental groups.  Medium conditioned by both fetal and adult dermal fibroblasts 
elicited a robust mitogenic response in interzone cells, paralleling that of the 
corresponding chondrocyte-derived conditioned medium.  Moreover, both fetal and 
adult dermal fibroblasts appear to be highly sensitive to mitogenic stimuli from fetal 
anlage chondrocytes compared to all other cell types.  These findings along with the fact 
that fibroblasts readily propagate in adherent monolayer culture suggest that they could 
be more primed for proliferation signals [112-114]. 
Additionally, differential production of mitogenic factors by fetal versus adult cells 
was evaluated.  Conditioned media derived from fetal chondrocytes were significantly 
more mitogenic (with a mean percent proliferation of 38 ± 2.33) compared to those 
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from adult chondrocytes (19 ± 0.92) (p value = 0.0035).  Conditioned media derived 
from fetal fibroblasts (40 ± 1.42) elicited significantly higher mitogenic response relative 
to adult fibroblasts (17 ± 3.45) (p value = 0.0008).  Our data indicate that paracrine 
stimuli from fetal cells have a significantly higher mitogenic ability or are secreted in 
higher quantities compared to those from adult cells.   
The conditioned medium system that we utilized in this study is a widely used 
indirect co-culture model for studying paracrine interactions between distinct cell 
populations.  It provides several advantages over other co-culture models including the 
ability to control the period of incubation and the volume of conditioned medium, and 
thus the quantity of paracrine signals delivered to the cells.  Additionally, the distinct 
physical locations of the cells allow tracking of the phenotypic and genotypic changes in 
the signal receiving cell and the directionality of signaling pathways [98, 115-118].  We 
found this co-culture model to be useful for assessing the mitogenic potential of 
paracrine signals from all the cell types tested.  
The data summarized above suggests a paracrine signaling between the interzone 
cells and the skeletal microenvironment which induce these cells to proliferate in 
culture.  In the transplantation studies in the axolotl salamander (discussed in Chapter 
2), cells within the new interzone layer of the accessory joint stain positively by GFP 
immunostaining indicating that they are derived directly from the transplanted 
interzone tissue.  Our in vitro findings support a model whereby the transplanted 
interzone cells proliferate to maintain an interzone pool, in response to paracrine signals 
from the skeletal environment of the bone diaphysis.  Further mechanistic studies will 
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be valuable in elucidating the signaling pathways and specific signaling molecules that 
are involved in regulating this paracrine interaction between interzone cells and their 
environment.  Many of the processes and regulatory pathways involved in development 
are recapitulated during repair.  Although the precise origin, fate and role of interzone 
cells in joint development is still unclear, a multitude of growth factors, signaling 
proteins and transcription factors have been shown to be involved in interzone cell 
specification and its function as the progenitors of joint tissues [47, 50, 78].  These could 
be potential candidates as regulators of cellular paracrine interactions between 
interzone and its environment.   
Studies reported in this chapter were aimed at evaluating an effect of 
microenviromental paracrine factors on interzone cell proliferation.  However, cell 
proliferation is not an independent event in development, and may actually occur 
closely with the fundamental processes of cell differentiation and migration, often 
involving some degree of overlap.  In the developing embryo, the unspecialized 
progenitor cells proliferate and increase in number, and subsequently differentiate into 
specialized cells.  There is concurrent physical migration of the cells to the appropriate 
anatomical location which is essential for patterning of the embryo.  This is regulated by 
both internal factors as well as external signals from the microenvironment.  These 
cellular and secreted signals play a vital role in mediating the communication between 
cells [95-97, 119, 120].  The accessory joint that formed in the tibial CSD with the 
interzone transplants was spatially patterned with cartilaginous structures that showed 
cellular morphologies resembling those of epiphyseal/articular and metaphyseal 
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chondrocytes.  GFP immunostaining confirmed their origin from the original interzone 
transplant tissue.  These findings suggest that interzone cells could be differentiating 
into multiple cell types with the paracrine signals from the skeletal microenvironment 
acting as differentiation cues.  Experiments in the following chapter focus on evaluating 
an effect of skeletal paracrine signals on chondrogenic differentiation of interzone cells.   
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Chapter 4 
Effect of skeletal paracrine signals on the chondrogenic differentiation of interzone 
cells 
 
Introduction  
Articular cartilage injuries do not heal completely in mammals, often resulting in 
progressive joint degeneration, and are associated with significant joint dysfunction and 
disability.  Current regenerative approaches in attempts to restore cartilage integrity in 
lesioned areas involve the use of stem or mesenchymal cells co-delivered with the 
appropriate extracellular matrix and trophic signaling molecules in order to ‘engineer’ a 
normal hyaline cartilage repair tissue.  Several adult multipotent cells and embryonic 
stem cells have been explored as potential sources for cell-based joint therapy [8, 13, 
14, 20, 121-123].  Interzone cells have attracted attention since they represent the 
normal progenitor of diarthrodial joints during development, forming the articular 
cartilage, synovial membrane and associated joint structures [48, 77, 89].  They have 
also been implicated in the repair of experimentally generated cartilage lesions in 
axolotl salamanders as described in Chapter 2 and reported previously [79, 80].  In 
addition, interzone cells remain viable when transplanted into a critical size skeletal 
defect and form a de novo joint.  This accessory joint exhibits accurate spatial patterning 
as seen in a normal diarthrodial joint with an interzone positioned between two 
cartilaginous columns that include cells morphologically resembling both 
epiphyseal/articular and metaphyseal chondrocytes.  At the time of the original surgery, 
interzone transplants were placed in random orientation in the axolotl salamanders.  
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However, approximately 7 months later, the cells that comprised the new accessory 
joint formed at the transplant site in the tibia diaphysis exhibited tissue organization 
resembling that of an intact joint.  These findings suggest two things.  First, that the 
axolotl interzone cells have an ability of self-renewal and multipotent differentiation 
that is characteristic of ‘stem cells’ [124, 125].  Second, that a local level of regulation 
and crosstalk exists between the transplanted interzone cells and the skeletal 
microenvironment.  The end result was the de novo joint with accurate anatomical 
orientation and organization of tissue types.  In contrast, the interzone cells placed in a 
non-skeletal site have limited viability and do not appear to differentiate into other cell 
types suggesting an absence of supportive trophic signals in the non-skeletal 
microenvironment.  Taken together, these data suggest a vital role of the skeletal 
microenvironment in contributing to and regulating the interzone-mediated repair of 
both a large joint lesion [79] and critical sized diaphyseal defect ([80] and Chapter 2).  
Many of the processes and mechanisms of tissue repair resemble events that 
occur during normal embryogenesis.  Undifferentiated progenitor cells in the developing 
embryo proceed through the processes of proliferation, migration, and differentiation 
to give rise to diverse and multiple cell types in the body [95-97, 119, 120].  
Chondrogenic differentiation is a critical process in the development of the embryonic 
skeleton.  Chondrocytes are derived from mesodermal skeletal progenitor cells that 
proceed through successive steps of lineage commitment and differentiation to become 
highly specialized tissues including bone and several different types of cartilage.  
Chondrocyte fate decisions and functions are tightly regulated in a spatial and temporal 
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manner by numerous extrinsic and intrinsic regulatory factors.  While many of the 
molecular and biomechanical mechanisms that govern chondrocyte differentiation 
continue to be areas of active research, it is clear that changing the type and strength of 
these extracellular signals allow diversity in the ultimate outcome.  Differentiation of 
chondrocytes from embryonic precursor cells is also associated with expression of two 
genes that encode major cartilage matrix components - type II collagen (COL2) and 
aggrecan (ACAN) core protein, both of which represent traditional biomarkers for 
cartilage [71, 126, 127]. 
Based on our observations from the transplantation studies in axolotl 
salamanders described in Chapter 2, fate of the transplanted interzone cells appears to 
depend on the cellular environment, likely reflecting at least in part differences in 
paracrine signals.  A better understanding of these signals may prove relevant when 
considering interzone cells as a potential new cell type for tissue-engineering in cartilage 
repair.  In this chapter, we employed a mammalian co-culture model to test the 
hypothesis that skeletal cell-derived paracrine signals induce interzone cells to 
differentiate along a chondrogenic lineage, an effect mediated at least in part by soluble 
paracrine factors originating from the skeletal cells.  Conditioned media were generated 
and normalized as described previously in Chapter 3, but interzone cells were 
maintained in high density pellet cultures to promote chondrogenic differentiation [128, 
129]. 
 
 
60 
 
Materials and methods 
Isolation and culture of cells 
Collection and isolation of primary cells from fetal and adult tissues were performed 
as described in Chapter 3.  A total of six primary cell lines isolated from five equine 
fetuses and five young adult horses were used.  This sample set included four cell types 
derived from skeletal tissues along with fibroblasts from skin as a control: 
 
1. Adult articular chondrocytes (AEC) 
2. Adult bone marrow derived cells (BM) 
3. Fetal anlage chondrocytes (FEC) 
4. Fetal interzone cells (IZ) 
5. Adult dermal fibroblasts (AEF) 
6. Fetal dermal fibroblasts (FEF) 
 
In addition, a sample of articular cartilage and dermis harvested from an age 
matched horse were snap frozen in liquid nitrogen for the subsequent isolation of total 
RNA to be used as control samples for gene expression analyses. 
 
Co-culture 
Media conditioned by fetal and adult primary cell lines of both skeletal and non-
skeletal tissue origins were the source of paracrine signals.  Interzone cells in high 
Skeletal cells 
Non-skeletal cells 
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density pellet cultures were used as the signal responders in all experiments as outlined 
in Table 4.1. 
                   
 
 
 
 
To generate P3 interzone cell pellets, thawed P2 cells were plated in complete 
medium (Dulbecco’s Modified Eagles Medium [DMEM, Gibco, Cat# 10569044] 
supplemented with 10% (v/v) heat inactivated Fetal Bovine Serum, 1% (v/v) P/S, and 1% 
amphotericin B) with the medium being replenished every 48 hours.  At 65-70% 
confluence, the cells were trypsinized, washed twice in serum free medium, and 
resuspended in the appropriate test conditioned medium or control medium at 500,000 
cells per ml.  One milliliter of cell suspension was then transferred to a 1.5 ml 
Table 4.1: Description of biological and technical replicates in experimental and control groups. FEF-
CM: Fetal dermal fibroblasts, FEC-CM: Fetal anlage chondrocytes, IZ-CM: Fetal interzone cells, AEF-CM: 
Adult dermal fibroblasts, AEC-CM: Adult articular chondrocytes and BM-CM: Bone marrow derived cells 
conditioned media. 
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polypropylene microcentrifuge tube and centrifuged at 500g for 3 minutes to generate a 
cell pellet as previously described [130-132].  After 48 hours, each pellet was transferred 
from the tube to an individual well of a 1% Poly (2-hydroxyethyl methacrylate) 
(polyHEMA; Sigma Cat# P3932) coated 24-well plate.  The polyHEMA coating enabled 
anchorage-independent growth of the pellets by preventing adhesion of the pellets to 
the surface of the well.  The pellets were maintained in the appropriate test conditioned 
medium or control medium for 21 days with re-feeding every 48 hours.  
 
Conditioned Medium and Controls 
Preparation, processing, and normalization of conditioned medium were 
performed as described in Chapter 3.  A total of 100 ml of conditioned media was 
generated from each biological replicate at 5 ml per T-75 flask to obtain sufficient 
volume for maintaining pellets for 21 days in culture.  
Chondrogenic induction medium was used as the positive control and comprised 
of DMEM, 1% penicillin/streptomycin, 1.25 mg/ml bovine serum albumin, 1x ITS-A 
growth supplement (Thermo Fisher Scientific, Cat# 51300044), 1x non-essential amino 
acids, 100 nM dexamethasone, 50 µg/ml ascorbate-2-phosphate, and 10 ng/ml rhTGFβ1 
(EMD Millipore, Cat# GF111) [131-135].  To optimize the negative control medium, 
interzone cell pellets were incubated in defined media with different components of the 
chondrogenic induction medium as outlined in Table 4.2, followed by an assessment of 
chondrogenic differentiation by morphological examination and matrix proteoglycan 
staining.  The objective was to identify a recipe that was as close as possible to the 
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positive control chondrogenic induction medium without actually inducing 
chondrogenesis. 
                 
 
Histological examination 
 The interzone cell pellets cultured for 21 days in each experimental medium 
preparation were pooled and then randomly allocated to either histology or gene 
expression subgroups.  For histological analyses, the pellets were fixed in 4% 
paraformaldehyde for 24 hours followed by pre-embedding in 2% agar/2.5% gelatin 
blocks at 2-3 pellets per block [136].  The blocks were then fixed in 4% 
paraformaldehyde for 24 hours prior to storage in 70% ethanol for histological 
processing.  Paraffin-embedded blocks were sectioned at 5 µm and stained with either 
Hematoxylin and Eosin (H&E) to assess pellet architecture or Safranin-O for 
proteoglycan content and distribution as described below.  Analysis of pellet 
Table 4.2 outlining the composition of types of defined media used to identify the negative control 
medium.  Group D is the chondrogenic induction/ positive control medium.  
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morphology and staining patterns were completed in consultation with a board certified 
pathologist (Dr. Jennifer Janes, personal communication).  
 
Proteoglycan staining and quantification 
Safranin-O is a stoichiometric cationic dye which in its orthochromatic form 
binds to the sulfate groups of proteoglycan molecules in a 1:1 fashion, making it semi-
quantitative [137-139].  Thus, the intensity of staining or ‘redness’ is approximately 
proportional to the proteoglycan content assuming the overall negative charge 
distribution of proteoglycans is uniform across all samples.  All sections were stained 
with 0.1% Safranin-O and a Fast Green counterstain in two batches to reduce inter-
batch technical variation.  Adult equine articular cartilage was included as a positive 
control calibration sample in both batches and randomly placed in each 30-slide rack.  
Mounted sections were imaged with a Nikon Eclipse Ti microscope at 10x in a darkened 
room to minimize ambient light.   
The ‘redness’ values of Safranin-O stained sections were measured using ImageJ 
Fiji software (https://imagej.nih.gov/ij/download.html) with the same microscope 
exposure and brightness settings maintained for all measurements.  Red balancing was 
performed to correct for the background from white microscope source light.  The 
contrast level for each pellet after red balancing was fixed and the color image was split 
into its corresponding red, green, and blue channels, thus effectively eliminating the 
interference from the green and blue background.  A histogram which linearly mapped 
the pixel values in the image to values ranging from 0 - 255 was generated for the red 
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channel for each image. The mean integrated density value which is a product of the 
area and the mean pixel value was computed for the red channel for each image and 
recorded for all samples.  
 
Gene expression analysis  
At the end of the 21 day culture period, pellets that had been randomly selected 
for gene expression analysis were rinsed with PBS and snap frozen in liquid nitrogen in 
batches of 3 pellets.  These samples were stored at -80°C for subsequent total RNA 
extraction.  Pellets were homogenized, starting while they were still frozen, in 2 ml of 
Qiazol (Qiagen, Cat# 79306), a guanidinium thiocyanate-phenol-chloroform extraction 
reagent (3 pellets/2ml).  Total RNA was isolated using a spin column-based kit with 
modifications as previously described [140].  RNA samples were purified by ethanol 
precipitation to remove any residual processing contaminants and quantified by 
fluorescence using the Qubit BR Assay or Qubit HS Assay (Life Technologies, Cat# 
Q10210, Q32852).  The removal of any potential contaminating genomic DNA followed 
by reverse transcription of total RNA to generate cDNA were performed using a 
commercially available kit (Maxima First Strand cDNA Synthesis Kit for RT-qPCR with 
dsDNase, Life Technologies, Cat# K1672) according to the manufacturer’s protocol.  The 
resulting cDNA was uniformly diluted to 0.67ng/µl with nuclease-free water and stored 
at -20°C in 100 µl aliquots.  The quantity of total RNA isolated from the pellet samples 
was a limiting variable in the number of transcripts that could be analyzed by RT-PCR.  
To maximize this number, we compared three low input quantities of RNA for their 
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feasibility and reproducibility in template amplification.  3 ng of template per reaction 
was identified as the lowest template amount that could be reliably amplified (data not 
shown).  Commercially available, validated equine-specific TaqMan primer probe sets, 
listed in Table 4.3, were used to quantitate steady state mRNA levels of ACAN, COL1A1 
and COL2A1 genes.  After evaluating four commercially available equine-specific 
endogenous control gene primer-probe sets, β2 microglobulin (B2M) was selected as 
the endogenous control, because it exhibited the most uniform level of expression 
across the experimental groups as recommended in MIQE guidelines [141].  The 
reactions were performed in 384 well plates in a total reaction volume of 10 µl.  
Nuclease-free water and a minus reverse transcriptase reaction served as the negative 
control samples.  Positive control and calibrator samples were a single age-matched 
sample of dermis (Dermis) for the analysis of COL1A1 expression and articular cartilage 
tissue (AAC) for the analysis of ACAN and COL2A1 expression.  All samples were 
analyzed in triplicate and randomly assigned to each plate to control for any plate 
effects.  Reactions were performed on a robotic ViiA™ 7 Real-Time PCR System (Thermo 
Fisher Scientific).  Reaction amplification efficiencies were evaluated using LinRegPCR 
[142] and then used to correct cycle threshold measurements for each sample.  Relative 
expression values (RE; relative quantity, RQ) of the transcript targets were calculated 
using the 2-ΔΔCt method [143].     
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Statistical analysis  
Redness values and individual lnRQ values from the qPCR data were 
independently evaluated by one-way analysis of variance.  Medium type (conditioned 
and control media) was the factor being tested at the following levels - Conditioned 
medium from Fetal dermal fibroblasts (FEF-CM), Fetal anlage chondrocytes (FEC-CM), 
Fetal interzone cells (IZ-CM), Adult dermal fibroblasts (AEF-CM), Adult articular 
chondrocytes (AEC-CM) and Bone marrow derived cells (BM-CM) and negative (basal 
medium), and positive control (chondrogenic induction medium).  Pair-wise 
comparisons were made between the different levels with Tukey’s post hoc correction 
for multiple comparisons.  Significance was defined at p <0.05.  Residual plots, 
histograms of residuals and Q-Q plot of residuals were evaluated to ensure that the 
normality assumptions were not violated.   
 
 
 
Table 4.3 listing the details of the TaqMan primer probe sets used in the qPCR reactions. 
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Results 
Controls 
Figure 4.1 shows histological images of interzone pellets from the different 
defined media stained with Safranin O and a Fast Green counterstain to identify the 
optimal negative control medium.  Proteoglycan molecules stain red with Safranin O, 
while a bluish green color from the Fast Green counterstain is observed when there is 
an absence of proteoglycan.  Positive matrix staining was observed only in the fully 
constituted chondrogenic medium.  Therefore, the media formulation used to culture 
Group C pellets, comprised of all components of the chondrogenic positive control 
medium minus TGFβ1 and dexamethasone, was selected for negative controls.  This 
medium was the closest in composition to the positive control medium, but did not 
demonstrate any evidence by histological assessment of chondrogenic differentiation.   
                                           
 
 
Figure 4.1 showing Safranin-O stained images of interzone pellets in defined media with selected 
components of chondrogenic induction medium outlined in Table 4.2 (A-C ). Positive staining was 
observed only in the chondrogenic medium (D).  All images are at 10x (objective lens) magnification.   
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Macroscopic assessment of pellets 
Interzone pellets in the experimental and control groups maintained their shape 
and integrity throughout the period of culture.  Pellets showed minimal variation in size 
with the positive and negative control pellets appearing slightly larger than others.  
Figure 4.2 shows their relative sizes on a 1 mm increment scale.   
                          
 
 
 
Morphological examination of pellets 
Figure 4.3 and 4.4 present representative images of pellets from control and all 
experimental groups of conditioned media, respectively.  In the positive control 
chondrogenic medium, interzone cell pellets showed an outer cell-dense rim of spindle 
shaped cells with minimal cell matrix.  This was followed by a middle zone of low 
cellularity (approximately 3-7 cell layers thick) comprising polygonal to spindle shaped 
cells with round to oval nuclei often found within lacunae, separated by a lightly 
basophilic matrix.  The center of the pellet was composed of what appeared to be 
necrotic cells and debris within an acidophilic matrix.  This pellet core was variably sized 
Figure 4.2 showing the relative sizes of pellets cultured in conditioned and control media. FEF-
CM: Fetal dermal fibroblasts, FEC-CM: Fetal anlage chondrocytes, IZ-CM: Fetal interzone cells, 
AEF-CM: Adult dermal fibroblasts, AEC-CM: Adult articular chondrocytes and BM-CM: Bone 
marrow derived cells conditioned media. 
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across biological replicates.  In contrast, this zonal appearance was absent to minimal in 
pellets maintained in the negative control medium.  Pellets appeared irregular in shape 
and lacked a cell-dense outer rim.  Spindle shaped to oval cells with round basophilic 
nuclei were observed distributed non-uniformly throughout the basophilic and 
sometimes fibrillar matrix of the pellets.  Necrotic areas and debris with admixed 
polygonal cells were seen unevenly distributed in the negative control pellets.  
 
Fetal cell lines  
Fetal dermal fibroblast conditioned medium (FEF-CM): Pellets showed a single layer of 
spindle shaped cells along the outer rim.  Islands of low to moderately acidophilic matrix 
with admixed oval to round cells were observed unevenly distributed throughout the 
pellet.  All pellets showed focal areas of necrosis and cell debris. 
Fetal anlage chondrocyte conditioned medium (FEC-CM): Streams of spindle shaped 
cells (approximately 2-5 cell layers thick) were observed along the periphery of all 
pellets.  Some of the pellet samples comprised focal clusters of polygonal to round cells 
surrounded by a basophilic matrix.  Areas of necrosis and cell debris were distributed 
throughout the pellet. 
Fetal interzone cell conditioned medium (IZ-CM): Pellets were composed of 
paucicellular zones of lightly basophilic matrix with round to oval cells.  Variably sized 
areas of necrotic cells and debris were distributed throughout the pellet.  A zone of 
homogenous, acellular matrix was observed circumferentially bordering some of the 
pellets in this group.   
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Adult cell lines 
Adult dermal fibroblast conditioned medium (AEF–CM): Pellets in this group showed a 
single layer of basophilic spindle cells arranged along the periphery.  A zone of 
homogenous, acellular matrix was observed circumferentially under the outer rim in 
some samples.  Variably sized areas of necrotic cells and debris were distributed 
throughout the pellets.  
 
Adult articular chondrocyte conditioned medium (AEC–CM): Pellets were composed of 
an outer, densely cellular rim of spindle shaped cells with acidophilic cytoplasm.  
Necrotic cells and debris with admixed oval to round cells within a densely acidophilic 
matrix were distributed throughout the pellet.  Pellets lacked a zonal organization. 
 
Bone marrow derived cell conditioned medium (BM-CM): The architecture of pellets in 
this group was highly variable.  All pellets showed an outer rim with spindle shaped 
cells.  A thick rim of homogenous matrix populated by relatively few cells with round to 
oval nuclei and acidophilic cytoplasm was observed in some samples.  Variably sized 
areas of necrosis and debris were observed towards the center of all pellets.  
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Proteoglycan staining and quantification 
Staining was performed in two consecutive batches with all conditions being 
maintained uniform between batches.  Figure 4.5 and 4.6 present representative images 
of pellets from control and all experimental groups of conditioned media, respectively.  
Figure 4.4: Panel showing hematoxylin and eosin stained sections of interzone pellets in conditioned 
media from FEF-CM: Fetal dermal fibroblasts, FEC-CM: Fetal anlage chondrocytes, IZ-CM: Fetal 
interzone cells, AEF-CM: Adult dermal fibroblasts, AEC-CM: Adult articular chondrocytes and BM-CM: 
Bone marrow derived cells at different objective lens magnifications as indicated at the left.  
Figure 4.3: Panel showing hematoxylin and eosin stained 
sections of interzone pellets in positive and negative control 
media at different objective lens magnifications.   
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The intensity of staining was quantified and recorded as the mean redness value as 
shown in Figure 4.7.  Pellets in the positive control medium demonstrated significantly 
higher proteoglycan staining in comparison with the negative control and all 
experimental groups.  The integrated density values were not significantly different 
between the conditioned media types. 
 
Fetal cell lines 
Pellets incubated in FEC-CM and IZ-CM demonstrated focal areas of marginally 
positive proteoglycan staining, however, there was considerable within-group variation 
in both groups.  These islands of proteoglycan staining were composed of round to 
polygonal cells separated by lacunae.  All pellets maintained in FEF-CM showed an 
absence of proteoglycan staining.   
 
Adult cell lines 
Pellets from AEC-CM and BM-CM demonstrated faint proteoglycan staining with 
round to oval cells, but the response was not uniform across all biological replicates of 
each group and did not reach statistical significance.  Pellets in AEF-CM did not show any 
evidence of staining for matrix proteoglycans.   
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Figure 4.6: Panel showing Safranin O – Fast green stained sections of interzone pellets in conditioned media 
from FEF-CM: Fetal dermal fibroblasts, FEC-CM: Fetal anlage chondrocytes, IZ-CM: Fetal interzone cells, 
AEF-CM: Adult dermal fibroblasts, AEC-CM: Adult articular chondrocytes and BM-CM: Bone marrow derived 
cells at different objective lens magnifications as indicated at the left.  
Figure 4.5: Panel showing Safranin O – Fast green stained sections of 
interzone pellets in positive and negative control media at different objective 
lens magnifications as indicated.   
 
75 
 
            
              
 
 
Gene expression analysis   
Aggrecan core protein (ACAN) 
Articular cartilage tissue consistently expresses high levels of ACAN.  As expected, 
ACAN mRNA expression was higher in articular cartilage tissue (AAC) compared to all 
other groups (Figure 4.8; Table 4.4) and was used as the calibrator sample.  The cell 
pellets maintained in chondrogenic medium (positive control; PC) showed significantly 
higher levels of ACAN expression than all other media types, approaching that of AAC.  
Pellets from the fetal cell-derived conditioned media exhibited significantly greater 
expression levels relative to the negative control (NC) pellets.  Interestingly, among the 
Figure 4.7: Semi-quantitative evaluation of proteoglycan staining – Box and whiskers plot depicting the log10 of 
Integrated density values of pellets in control and conditioned media. FEF-CM: Fetal dermal fibroblasts, FEC-
CM: Fetal anlage chondrocytes, IZ-CM: Fetal interzone cells, AEF-CM: Adult dermal fibroblasts, AEC-CM: Adult 
articular chondrocytes and BM-CM: Bone marrow derived cells conditioned media. AAC – Adult articular 
cartilage tissue PC – positive control medium, NC – negative control medium. Different letters indicate 
significant differences between groups. 
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types of conditioned media, the highest level of ACAN expression was seen in pellets in 
FEC-CM relative to negative control (p<0.001).   
 
      
 
 
  
        
 
Figure 4.8: Box and whiskers plot illustrating steady state mRNA expression of ACAN in pellets from conditioned 
and control media relative to articular cartilage tissue (set to 0).  Diamonds within the box plot represent the 
group mean.  FEF-CM: Fetal dermal fibroblasts, FEC-CM: Fetal anlage chondrocytes, IZ-CM: Fetal interzone cells, 
AEF-CM: Adult dermal fibroblasts, AEC-CM: Adult articular chondrocytes and BM-CM: Bone marrow derived cells 
conditioned media. AAC – Adult articular cartilage tissue, PC – positive control medium, NC – negative control 
medium. Diamonds within the box plot represent the group mean.  
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Type II collagen (COL2A1) 
Expression patterns of COL2A1 mRNA were similar to that of ACAN in all media 
and tissue types tested (Figure 4.9; Table 4.5).  Steady state mRNA levels of COL2A1 
were significantly higher in AAC and positive control pellets in comparison with all other 
groups.  In general, pellets in the fetal conditioned media exhibited higher levels of 
expression relative to the adult set.  Interestingly, COL2A1 mRNA levels were 
significantly higher in pellets maintained in FEC-CM (p = 0.0082) and IZ-CM (p = 0.001) 
relative to those in the negative control medium. 
Medium 
type/ACAN AAC AEC - CM AEF - CM BM - CM Dermis FEC - CM FEF - CM IZ - CM NC PC
AAC 0.0002 <.0001 <.0001 <.0001 0.0518 0.0015 0.0047 <.0001 0.8504
AEC - CM 0.9965 0.9985 0.1996 0.3023 0.9982 0.9453 0.2295 <.0001
AEF - CM 1 0.5622 0.0479 0.8046 0.4849 0.8193 <.0001
BM - CM 0.516 0.0601 0.8508 0.5455 0.7607 <.0001
Dermis 0.0015 0.0527 0.0196 0.9852 <.0001
FEC - CM 0.7919 0.9708 <.0001 0.1516
FEF - CM 1 0.0284 0.0008
IZ - CM 0.0056 0.0047
NC <.0001
PC
Table 4.4 listing the p-values of differences in ACAN expression as measured by steady state levels of mRNA in different 
media types.  Significant differences are depicted by pink shading (p<0.05 – Tukey’s post hoc correction). FEF-CM: Fetal 
dermal fibroblasts, FEC-CM: Fetal anlage chondrocytes, IZ-CM: Fetal interzone cells, AEF-CM: Adult dermal fibroblasts, 
AEC-CM: Adult articular chondrocytes and BM-CM: Bone marrow derived cells conditioned media. AAC – Adult articular 
cartilage tissue, PC – positive control medium, NC – negative control medium.  
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Medium 
type/Col2A1 AAC AEC - CM AEF - CM BM - CM Dermis FEC - CM FEF - CM IZ - CM NC PC
AAC <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 0.4615
AEC - CM 0.9999 1 0.0012 0.2532 0.8612 0.067 0.988 <.0001
AEF - CM 0.9993 0.0003 0.5689 0.9897 0.2145 0.8099 <.0001
BM - CM 0.0017 0.1868 0.7802 0.0454 0.9971 <.0001
Dermis <.0001 <.0001 <.0001 0.0034 <.0001
FEC - CM 0.9876 0.9997 0.0082 <.0001
FEF - CM 0.8042 0.1609 <.0001
IZ - CM 0.001 <.0001
NC <.0001
PC
Figure 4.9: Box and whiskers plot illustrating steady state mRNA expression of COL2A1 in pellets from conditioned 
and control media relative to articular cartilage tissue (set to 0) which was used as the calibrator sample.  Diamonds 
within the box plot represent the group mean.  FEF-CM: Fetal dermal fibroblasts, FEC-CM: Fetal anlage chondrocytes, 
IZ-CM: Fetal interzone cells, AEF-CM: Adult dermal fibroblasts, AEC-CM: Adult articular chondrocytes and BM-CM: 
Bone marrow derived cells conditioned media. AAC – Adult articular cartilage tissue, PC – positive control medium, 
NC – negative control medium. Diamonds within the box plot represent the group mean.  
 
Table 4.5 listing the p-values of differences in COL2A1 expression as measured by steady state levels of mRNA in 
different media types.  Significant differences are depicted by pink shading (p<0.05 – Tukey’s post hoc correction). FEF-
CM: Fetal dermal fibroblasts, FEC-CM: Fetal anlage chondrocytes, IZ-CM: Fetal interzone cells, AEF-CM: Adult dermal 
fibroblasts, AEC-CM: Adult articular chondrocytes and BM-CM: Bone marrow derived cells conditioned media. AAC – 
Adult articular cartilage tissue, PC – positive control medium, NC – negative control medium.  
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Type I collagen (COL1A1) 
Expression of COL1A1 was variable in all groups, but relatively higher in the 
pellets maintained in fetal conditioned media than those in the adult conditioned media 
(Figure 4.10; Table 4.6).  The level of expression in dermis was set to zero and was used 
as the calibrator sample.  Pellets in FEC-CM showed significantly higher levels of 
expression compared to the negative control (p=0.0182).   
 
                  
 
                                      
 
 
Figure 4.10: Box and whiskers plot illustrating steady state mRNA expression of COL1A1 in pellets from 
conditioned and control media relative to dermis tissue (set to 0) which was used as the calibrator sample.  
Diamonds within the box plot represent the group mean.  FEF-CM: Fetal dermal fibroblasts, FEC-CM: Fetal 
anlage chondrocytes, IZ-CM: Fetal interzone cells, AEF-CM: Adult dermal fibroblasts, AEC-CM: Adult articular 
chondrocytes and BM-CM: Bone marrow derived cells conditioned media. AAC – Adult articular cartilage 
tissue, PC – positive control medium, NC – negative control medium. Diamonds within the box plot represent 
the group mean.  
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Discussion      
The data from experiments described in this chapter suggests the production of 
paracrine signals by the skeletal tissue derived primary cell lines that induce 
chondrogenic differentiation in interzone cells.  However, the magnitude of this effect 
with the methods used was limited.  Interzone cell pellets cultured in skeletal cell 
derived conditioned media showed weak proteoglycan staining, however, the response 
was highly variable within all groups.  Still, this response was greater than that observed 
in conditioned medium from fetal and adult fibroblasts.  None of the interzone pellets 
cultured with fetal or adult fibroblast conditioned medium demonstrated any evidence 
of positive matrix proteoglycan staining.  
The data from gene expression analysis were generally consistent with the results of 
matrix staining.  Expression of the cartilage biomarker genes ACAN and COL2A1 were 
higher in the pellets cultured with skeletal cell-derived conditioned media.  As with the 
Medium 
type/Col1A1 AAC AEC - CM AEF - CM BM - CM Dermis FEC - CM FEF - CM IZ - CM NC PC
AAC 0.0583 0.56 0.6687 0.0119 <.0001 <.0001 0.0005 0.0415 <.0001
AEC - CM 0.8349 0.7122 0.9286 0.0926 0.1086 0.4585 1 0.1159
AEF - CM 1 0.2555 0.0012 0.0014 0.0141 0.7975 0.0007
BM - CM 0.1867 0.0006 0.0007 0.0076 0.6443 0.0003
Dermis 0.9929 0.9953 1 0.8371 0.9997
FEC - CM 1 0.9968 0.0182 0.9999
FEF - CM 0.9983 0.0227 1
IZ - CM 0.1914 1
NC 0.0127
PC
Table 4.6 listing the p-values of differences in COL1A1 expression as measured by steady state levels of 
mRNA in different media types.  Significant differences are depicted by pink shading (p<0.05 – Tukey’s 
post hoc correction). FEF-CM: Fetal dermal fibroblasts, FEC-CM: Fetal anlage chondrocytes, IZ-CM: Fetal 
interzone cells, AEF-CM: Adult dermal fibroblasts, AEC-CM: Adult articular chondrocytes and BM-CM: 
Bone marrow derived cells conditioned media. AAC – Adult articular cartilage tissue, PC – positive 
control medium, NC – negative control medium.  
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Safranin-O staining, however, the magnitude was small relative to steady state mRNA 
levels observed in the positive controls.  Within the experimental groups, pellets in the 
FEC-CM appeared to elicit the most robust chondrogenic differentiation response as 
evidenced by significantly higher expression of ACAN and COL2A1 relative to negative 
controls.  The expression of COL1A1 in all groups of pellets is consistent with both an 
absence (negative control, FEF-CM, AEF-CM) and incomplete (conditioned medium from 
skeletal cell-derived conditioned medium, positive control) level of chondrogenic 
differentiation.  Only adult articular cartilage tissue had negligible COL1A1 steady state 
mRNA levels. 
Based on the data presented in this chapter, the evidence for a robust chondrogenic 
induction response is limited.  Possible reasons for this could be that the cells are not 
secreting any chondroinductive signals or, that the levels of paracrine chondroinductive 
signals accumulated in the conditioned media with the methods used could be 
insufficient to elicit a profound response.  It is worth noting that these were functional 
assays and were not designed to characterize the quantity or integrity of factors known 
to have chondroinductive ability.  The proliferation assays described in Chapter 3 were 
performed on interzone cells in monolayer culture while assessment of chondrogenic 
differentiation was performed on pellet cultures of interzone cells.  These cell culture 
formats were adopted to ensure an optimal system for cells to respond to paracrine 
inductive signals in culture.  However, the source of paracrine signals, namely the 
conditioned media was generated from cells in monolayer which could be biased 
towards proliferation and not chondrogenic differentiation.  Traditionally, the 
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fundamental cellular processes of proliferation and differentiation are believed to have 
an inverse relationship, wherein cells initially undergo active cell division and as they 
start to differentiate, they down regulate the genes for proliferation [95, 106, 119, 144, 
145].  Therefore, the conditioned medium could likely have been enriched for signaling 
proteins and growth factors involved in cell division and might be lacking 
chondroinductive signals.  In addition, conditioned medium was generated by 24 hours 
of incubation with cells.  While this was likely sufficient for the mitogenic stimuli from 
cells to accrue in the media, this short period of incubation might have limited the 
amount of chondrogenic signals elaborated by the cells.  These could be possible 
reasons for the limited chondrogenic induction that we observed from all types of 
conditioned media in our experiments.  It could also be that interzone cells are 
unresponsive to the paracrine signals present in the conditioned medium.  Another 
likely explanation is that a chondrogenic effect, if any, is beyond the resolution that we 
can robustly measure using proteoglycan staining and steady state mRNA levels of ACAN 
and COL2A1.  We observed considerable variation within the skeletal cell conditioned 
medium groups, among which the BM-CM group was the most variable.  This could be a 
result of the diversity in the source of bone marrow derived cells as suggested by Cote 
et. al., 2016 [146].   
The data presented in this chapter alone does not strongly support or refute a model 
whereby paracrine signaling from the cells in the skeletal tissue microenvironment 
induces interzone cells to undergo chondrogenic differentiation.  Further experiments 
employing more sensitive experimental systems and assessment strategies are essential 
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in understanding the interaction between interzone cells and their skeletal 
environment.  It would be worth assessing these paracrine interactions using an indirect 
coculture system whereby cells are physically separated by a semi-permeable 
membrane but share media and secreted signals [86, 98, 147].  This system could allow 
for a more real-time analysis of cellular interactions between the interzone cells and the 
skeletal microenvironment.  We used cartilage biomarker expression, evaluated at both 
RNA and protein levels, to assess chondrogenic differentiation.  Recent advances in high 
throughput sequencing platforms facilitate characterization of global patterns of gene 
expression in samples both quantitatively and qualitatively.  This offers a valuable 
resource to identify the gene expression patterns unique to articular cartilage which 
could result in more sensitive strategies to assess chondrogenic differentiation.  It would 
also be interesting to examine the differential gene expression patterns in interzone 
cells in monolayer versus high density pellet cultures.  This information could be useful 
in identifying the molecular signals regulating interzone cell proliferation and 
chondrogenic differentiation and could contribute to additional mechanistic studies to 
elucidate these regulatory mechanisms.  Much progress has been made in this regard 
facilitated by an RNA-seq dataset generated for cells in monolayer and pellet cultures 
using aliquots from the same primary cell preparations used in this study [107].  This 
dataset also represents an opportunity to identify additional biomarkers of 
chondrogenic differentiation that could allow us to reexamine our data for assessment 
of chondrogenic differentiation.  These studies will be of relevance when considering 
interzone cells in cell-based therapeutic strategies for repair of the joint cartilage.     
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     Chapter 5 
Reflections and looking ahead to future studies 
 
Reflections 
Research efforts in this dissertation were directed towards understanding the 
cellular and molecular mechanisms of interzone-mediated repair of skeletal defects.  
Within this dissertation, results have been reported for experiments that have been 
performed to meet the following objectives 1) to examine the role of the 
microenvironment on the process of interzone-mediated repair, 2) to determine 
whether the fundamental cellular processes of proliferation and chondrogenic 
differentiation of interzone cells are regulated by extrinsic paracrine signals from their 
microenvironment.   
With the advent of tissue engineering strategies for cartilage repair, adult and 
embryonic mesenchymal cells have been explored for their potential to repair articular 
cartilage and restore normal joint function [20, 101, 148-150].  Interzone cells have been 
implicated both in the development and repair of articular cartilage in studies described 
in previous chapters.  Therefore, a complete understanding of the mechanisms of 
interzone-mediated repair, or more specifically the contribution of interzone cells versus 
environmental paracrine regulatory mechanisms, to this repair process is relevant with 
regard to their potential use as therapy cells for reengineering articular cartilage.   
The data presented in chapter 2 evaluated the functionality of interzone cells in 
an in vivo model by comparing the outcomes of interzone transplantation in skeletal and 
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non-skeletal sites in axolotl salamanders.  Repair was observed only in the skeletal 
environment whereas the transplanted cells could not be located in a majority of the 
samples in the non-skeletal site.  The interpretation of these findings is that the skeletal 
environment selectively supports and influences the proliferation and differentiation of 
interzone cells.  One possibility for this differential response could be a potential 
disparity in the quantity and duration of localized growth factor production between the 
two surgical sites.  The large induced lesion in the tibial diaphysis could have 
experienced more local trauma from the surgical procedure and could be expected to 
take longer to heal.  This offers an extended period of time when there is localized 
growth factor production which could also be stimulating the transplanted interzone 
cells.  In contrast, the degree and duration of stimulation by localized growth factors in 
the non-skeletal site could be limited owing to lower trauma and rapid tissue repair.  
Further characterization of the repair response in this in vivo model was hampered by 
the absence of a reference genome for the axolotl salamander which could have 
enabled efficient lineage tracing of the transplanted cells.  In addition, considerable 
challenges in culturing salamander cells, in an effort to isolate a homogenous cell 
population, prompted me to utilize an alternate in vitro model using equine primary 
cells.  While having to reconsider and retool the experimental systems to test our 
hypothesis may have slowed the pace of this study to some extent, it was a valuable and 
enriching educational experience in experimental biology and discovery science.  
In the research presented in Chapter 3, the hypothesis tested was that skeletal 
cell-derived paracrine factors play a vital role in regulating the proliferation of interzone 
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cells in an in vitro model and thus, contributing to the interzone-mediated repair 
process.  Media conditioned by the primary cells and therefore, termed ‘conditioned 
medium’ was used to evaluate how skeletal and non-skeletal cells differ in the 
production and response to mitogenic signals.  Our findings from this study supported 
the hypothesis.  The interzone cells showed a robust mitogenic response with all 
conditioned media types.  There are limitations to this study that need to be addressed 
in future studies.  First, normalization of the medium was performed based on the 
number of cells which conditioned the media.  Limitations associated with trypsinization 
and/or cell counting techniques could have affected the accuracy of normalization and 
contributed to the variation that we observed.  Secondly, all in vitro models, especially 
methods used to prepare the conditioned media, are approximations of the actual 
biological system and the complex signaling pathways that regulate cellular processes in 
the body.  The conditioned medium was used in an attempt to represent the soluble 
and stable paracrine signals that are constitutively secreted into the culture medium by 
cells.  While employing this system has enabled an understanding of the effect of these 
paracrine mitogenic stimuli on interzone cells, it does not account for insoluble, 
transient or unstable proteins that are secreted in a regulated fashion which could also 
be contributing to tissue repair.  Furthermore, the conditioned medium was 
supplemented with a significant quantity of bovine serum albumin (BSA) in order to 
maintain the total protein concentration uniform across experimental and control 
media.  However, this may have interfered with characterization of the cell’s secretome 
in the conditioned media using traditional protein quantification assays.  
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Studies in Chapter 4 used the same experimental system to evaluate a potential 
effect of environmental paracrine signals on the chondrogenic differentiation of 
interzone cells in high density pellet cultures.  While our findings were suggestive of 
paracrine signaling between the skeletal cells and interzone cells that likely induces 
chondrogenic differentiation, the magnitude of differences were not compelling.  There 
are several limitations with this study that would be worth considering during the design 
of any future studies.  First, the medium conditioned by cells in monolayer may have 
been inadequate to assess chondrogenic differentiation as these may have been 
preferentially enriched for mitogenic paracrine signals and with only low levels of 
chondrogenic stimuli.  However, there are considerable logistical challenges to using 
cells in three dimensional cultures to generate conditioned media such as high cell 
numbers required to condition the media and optimal culture conditions that would 
maintain cell viability while minimizing background differentiation, to name a few.  The 
levels of chondroinductive signals secreted by cells during the short period of 
conditioning may have been insufficient to elicit a response at the resolution that we 
could efficiently measure by cartilage biomarker expression on a gene and protein level.   
The data reported in this dissertation have contributed to the increasing pool of 
knowledge on the biology of interzone cells, suggesting that they are not autonomous; 
rather, their fate is influenced and regulated at least partly by external environmental 
cues.  The work presented here represents a “piece of the puzzle” that ongoing research 
efforts in our laboratory and the orthopedic research community are working to put 
together.  Additional studies are needed to elucidate the intricate signaling pathways 
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that are involved in cell-cell communication, which would be of relevance in 
consideration of interzone cells for cell-based repair strategies for articular cartilage. 
 
Future studies 
The studies described in this dissertation have led to an improved understanding 
of the functionality of interzone cells, with regard to their interaction with the 
microenvironment.  However, shortfalls of the in vitro co-culture model used limit our 
ability to dissect the precise signaling cascades that mediate the crosstalk between 
interzone cells and their environment.  Due to logistical challenges, the conditioned 
medium requires storage before use which limits our ability to examine soluble 
paracrine signals with short half-lives.  In addition, it does not allow for assessment of 
reciprocal signaling between cells [100].  Furthermore, the in vitro system fails to 
simulate the complexity of interactions between multiple cell types that comprise a 
tissue and the regulatory molecules that govern these interactions which could function 
in a synergistic or antagonistic manner.  These reflections are not meant to diminish the 
significance of this work, on the contrary, to emphasize the importance of expanding on 
it.  It would be worth re-examining the paracrine and possibly other interactions in more 
refined direct or indirect coculture models.  One promising model is an indirect 
coculture system employing membrane inserts which allows physical separation of the 
cells but permit sharing of media and signaling molecules between them [98, 147, 151, 
152].  This is a better representation of the biological system as cells are in constant 
communication with their neighbors during the entire culture period and it accounts for 
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the transient paracrine protein factors that have a regulated secretory pathway.  It also 
enables characterization of a reciprocal interaction between both participating cell 
types.  Employing mixed cultures of skeletal cells would be useful in reproducing the 
complexity of the biological system and enabling a better understanding of these 
cellular interactions.  More sensitive matrices for assessment of chondrogenic 
differentiation need to be developed and optimized.  With the advent of high 
throughput sequencing technology, analysis of global gene expression patterns of large 
sample sets can be performed with relative ease.  This could be a valuable resource in 
identifying additional biomarkers for articular cartilage and interzone.  Efforts in this 
regard are already underway in our laboratory being facilitated by an RNA-seq data set 
generated from equine cartilage and interzone at relevant developmental stages [107].  
Establishing a transcriptome signature for interzone cells would also be valuable for 
lineage tracing experiments to elucidate the origin and fate of interzone cells in 
development and repair. 
Additionally, questions remain with regard to what are the specific paracrine 
signals that induce proliferation and the limited chondrogenic differentiation of 
interzone cells in culture.  As discussed above, analyzing the conditioned medium using 
traditional protein detection and quantification methods to identify secreted paracrine 
proteins, which are often present in pico or nanogram quantities, was hindered by the 
significant amount of BSA (3 mg/ml) in our conditioned medium.  Employing a serum-
free and protein-free medium in future studies will help minimize this interference from 
BSA and enable detection and quantification of the cell secretome in the conditioned 
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medium.  Further mechanistic studies are needed to parse out the precise signaling 
pathways orchestrating this cell-cell communication.  Identification of such signaling 
molecule(s) that can induce interzone cells to differentiate into and maintain an 
articular cartilage phenotype could open several avenues for cartilage tissue repair.  
Advances in molecular biology have enabled access to tools for manipulation of specific 
molecular signals using knock out, knock down or over-expression strategies in mice.  
Utilizing these approaches to gain a better understanding of the role of paracrine signals 
in interzone cell biology would be valuable.  Furthermore, with the technology on IPS 
cells  infiltrating many aspects of cell biology and medical applications [153], identifying 
a master regulatory switch that can drive stable chondrogenic differentiation in 
interzone cells can have massive implications in the field of orthopedic regenerative 
medicine.  One could envision a point in the future when reprogramming patient-
derived somatic cells to induce an interzone cell phenotype capable of producing a 
durable and functional hyaline cartilage repair tissue to replace injured cartilage is a 
reality.    
One of the unique features of the axolotl salamander model is the retention of 
interzone in the intraarticular space through adulthood.  In mammals, the interzone can 
no longer be appreciated once the joint undergoes cavitation, an event that occurs 
within the first trimester of gestation.  Lineage tracing studies in mice have suggested 
that interzone is incorporated into the articular tissues during development [48, 49].  In 
our transplantation studies in the axolotl salamander, the interzone placed in the 
diaphyseal bone defect appears to proliferate and differentiate into multiple cartilage 
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types based on histological examination and GFP immunostaining.  These observations 
are suggestive of some degree of ‘stemness’ as self-renewal and multipotency are 
characteristic attributes of stem cells [124, 125, 154].  This leads us to the interesting 
question of whether there could be a reserve interzone-derived stem cell population in 
postnatal mammalian joints with potential regenerative capacity but which are 
maintained in a quiescent state through adulthood.  Identifying the molecular signal(s) 
that can potentially activate these cells to reenter the stem cell life cycle could hold 
exciting prospects for cartilage repair.  In fact, several studies have suggested the 
presence of chondroprogenitor cells in the superficial zone of articular cartilage in 
human, bovine and equine models [42, 155-158].  However, comparisons between 
these studies is challenging due to a lack of uniformity between stem cell surface 
markers across species and precise protocols to assess the nature of stem cells.  Further 
studies to characterize the stemness of equine interzone cells would be valuable in 
addressing these questions.  
During development, the growth and patterning of embryonic tissues is tightly 
regulated by dynamic patterns of expression of intrinsic and extrinsic signals which 
often act as morphogens.  Their concentration gradients set the positional information 
for recruitment and differentiation of cells [159].  In our studies in the axolotl 
salamander, the accessory joint that formed in the critical sized defect followed 
accurate spatial patterning although the interzone cells were transplanted with no 
consideration of orientation.  In addition, a zonal organization could be appreciated in 
interzone cell pellets that were induced to differentiate along a chondrogenic lineage 
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(Chapter 4; Figure 4.3 and 4.5 – positive control).  These observations in the in vivo and 
in vitro models are reminiscent of the controlled processes of growth and pattern 
formation in the developing embryo.  Further studies are necessary to understand why 
and how interzone cells achieve this spatial patterning.  What are the intrinsic and/or 
extrinsic regulatory mechanisms that govern this process?  Do interzone cells retain a 
memory of their polarity even when removed from their environment?  
Characterization of the zonal organization of induced interzone pellets would be 
valuable in order to help address these questions.  A recent lineage tracing study using 
knockin GDF5-CreER mice suggests a role for GDF5 in the recruitment and 
differentiation of interzone cells in the developing joint.  The authors propose that 
spatio-temporal patterns of GDF5 expression determine the lineage of interzone cells 
populating the GDF5 domain [78].  With additional studies emphasizing the importance 
of GDF5 in joint formation [47, 50, 77], it is tempting to speculate that GDF5 could be a 
potential master switch regulating the fate and function of interzone cells. 
 The experiments reported in this dissertation examine a potential effect of 
skeletal cells on interzone cells.  However, as in the biological system, this could be a bi-
directional interaction.  Additional studies are necessary to understand how interzone 
cells communicate with its microenvironment and how these external stimuli affect the 
behavior of interzone cells both in vitro and in vivo.  These could be performed 
employing an indirect or direct coculture system as discussed above.  Finally, while in 
vitro models are essential in understanding the behavior of cells and their regulation, it 
is important to translate this knowledge for clinical use using in vivo models.  There have 
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been significant advances in the field of regenerative medicine involving tissue 
engineering approaches in the last few years [105, 160, 161].  This offers the possibility 
of generating a repair tissue incorporating interzone cells co-delivered with the 
appropriate biomaterial scaffold and/or microenviromental signaling molecules.  
Engineering a functional cartilage repair tissue using these emergent strategies and 
further evaluation of its functionality in an in vivo mammalian model should be a long-
term goal in translational research.  
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